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Tissue engineering is a multi-disciplinary field that bring into play expertise in biology and engineering 
to develop biomimetic tissue constructs. These days, it would be not enough to mimic the physical and 
biological properties of the native tissue because various cells possess different physical properties such 
as stiffness or diffusion. Therefore, we need to develop artificial tissues within 3D formation resembling 
the natural extracellular matrix (ECM) microenvironment in order to observe more closely to mimic 
native tissues. Hydrogel is very useful materials in that hydrophilic and good properties high swelling 
ratio. Also, it can be possible to control mechanical and chemical properties and applied for tissue 
engineering fields.
This thesis indicates the development of three-dimensional microfluidic devices for cellular studies 
based on applications such as high throughput cell encapsulated beads culture and cell-based assay. 
With microfluidics, we can generate cell encapsulated microgel which can be possible to observe cell 
morphology or drug test due to high diffusion compare to bulk size hydrogel. Microfluidics has a lot of 
benefits such as low cost, low consuming reagent, fast analysis and portable device and so on. I used 
this platform such as microfluidic chip in order to generate cell encapsulated beads with uniform size. 
I used Gelatin which is derived from collagen that is biocompatible polymer. I synthesis from gelatin 
to GelMa using some reagent during 48h. GelMa can react cross-linking by UV light due to cleavage 
double bond by radical reaction. And already GelMa has RGD site which can attach binding part with 
cell, therefore cell grows good environment likely ECM structure. And I can control the polymer 
stiffness using various GelMA concentration.
This thesis is organized as follows: 
In chapter I is general introduction related to properties of basic microfluidics and microfluidic 
fabrication. 
In chapter II is introduction of tissue engineering, hydrogel and various cells. 
In chapter III is that Generated macrophage encapsulated beads using microfluidic chip and observed 
cell morphology by different stiffness and stimulated protein such as LPS (lipopolysaccharide). 
In chapter IV is that Co-culture system with macrophage and MCF-7 in order to obtain more cohesive 
spheroid in microgel. In chapter V is that Generation of breast cancer such as MDA-MB-231, MCF-7, 
SK-BR-3 encapsulated beads and observed cell morphology by different stiffness and two kind of 
chemotherapeutics such paclitaxel and cisplatin. 
Finally, I presented hollow fiber to mimic blood vessel using endothelial cell and observed cell 
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Part I : General Introduction
Figure 1.1. Droplet generating method in the flow focusing device.
Figure 1.2. (a) This image is CAD file (b) Fabrication of microfluidic chip using PDMS (c) With 
microfluidic chip and generating droplet.
Figure 1.3. The process of PDMS microfluidic chip fabrication. 
Part II : Introduction
Figure 2.1. The three kind of part are related to tissue engineering. The combination of cells, signals 
and scaffolds is used to engineer functional tissues.
Figure 2.2. Complex three-dimensional structure of extracellular matrix (ECM) and ECM-cell 
interactions.
Figure 2.3. Stem cells exert forces and they are affected by external forces, which controlled their 
intracellular signaling pathways.
Figure 2.4. Important materials design considerations for tissue engineering, containing cell adhesion 
peptide, protease sensitive peptide for cell mediated matrix degradation, and presence of signaling 
molecules. 
Figure 2.5. Synthesis hydrogels with good mechanical properties.
Part III : Microfluidics-assisted fabrication of macrophage microtissues with 
tunable physical properties for developing in vitro multiplex tissue 
model
Figure 3.1. Schematics of the microfluidic device with double flow-focusing channel geometry to 
develop cell-laden microgels.
Figure 3.2. 1H-NMR spectra of (a) MGel and (b) degraded MGel hydrogel. The methacrylic peaks (a, 
b) disappeared after gelation.
Figure 3.3. (a) Schematic illustration of a double flow-focusing microfluidic fabrication of 
macrophage-laden microgels. (b) Elastic moduli (E) and swelling ratios (Q) of photo-crosslinked MGel 
hydrogels at various concentrations.
Figure 3.4. A microscopic image of a cell-encapsulated droplet showing a distinct core-shell interface.
Figure 3.5. (a) Control of droplet diameters by ratios of aqueous-to-oil flow rates (QAq/QO). (b) Phase 
contrast and fluorescent images of macrophage-laden microgels with varying size. (c) The viability of 
cells encapsulated in microgels with varying size (scale bar: 50 μm) at day 1. D1=100 μm, D2=120 μm, 
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D3=160 μm, D4=200 μm.
Figure 3.6. Microfluidic generation of gel-precursor droplets at varying ratios of aqueous-to-oil flow 
rates (QAq/QO). (a) QAq/QO = 0.095, (b) QAq/QO = 0.21, (c) QAq/QO = 0.32, (d) QAq/QO = 0.45 (scale bar: 
200 μm).
Figure 3.7. The viability of cells encapsulated in droplets having various sizes measured before photo-
crosslinking to develop cell-laden microgels. D1=100 μm, D2=120 μm, D3=160μm, D4=200 μm. (scale 
bar: 50 μm)
Figure 3.8. Cell viability and proliferation in microgels at C2 (Aq1/Aq2=9%/12%) (a) Microscopic 
(upper) and fluorescent (lower) images of macrophages encapsulated in microgels taken at various 
times. The cells were fluorescently stained to identify live (green) and dead (red) cells (scale bar: 50 
μm). (b) viability of macrophages at various times during culture up to 7 days. (c) The normalized 
number of viable cells (Nt/N0) in the microgels was measured over time. (d) The plot in (c) was fitted 
with a power-law model to obtain the proliferation rates (kP) (*p<0.05).
Figure 3.9. Cell viability and proliferation in microgels at (a) C1 (Aq1/Aq2 = 7% / 10%) and (b) 
C3(Aq1/Aq2 = 11% / 14%). Microscopic (upper) and fluorescent (lower) images of macrophages 
encapsulated in microgels taken at various times. The cells were fluorescently stained to identify live 
(green) and dead (red) cells (scale bar: 50 μm).
Figure 3.10. The viability of cells encapsulated in microgels with varying size at day 3 (scale bar: 50 
μm). D1=100 μm, D2=120 μm, D3=160 μm, D4=200 μm.
Figure 3.11. (a) Differentiation of macrophages in microgels. (a) Microscopic images of macrophages 
in different microgels treated with LPS at day 7 (scale bar: 50 μm). Differentiated cells demonstrate 
sprouting formation. (b) The viability of macrophages at various times during culture up to 7 days. (c) 
The percentage of differentiated macrophages in the microgel.
Figure 3.12. Microscopic images of macrophage encapsulated in MGel microgels at varying
concentrations (C1, C2 and C3) treated with LPS to induce Mϕ polarization (scale bar: 50 μm).
Figure 3.13. Microscopic images of macrophage cells cultured on the surfaces of MGel hydrogels at 
varying concentrations (C1, C2, and C3) which were prepared separately to assess the effects of culture 
conditions (2D vs. 3D) on the macrophage proliferation (scale bar: 200 μm). The initial cell adhesion 
and proliferation were monitored over time.
Figure 3.14. Immunocytochemical analysis of macrophage-laden microgels at different mechanical 
properties: (a) C1, (b) C2, (c) C3.
Figure 3.15. (a) Macrophage-laden microgels were embedded into a larger fibroblast tissue construct 
to fabricate multiplex tissue model. (b,c) The changes in their phenotypes were monitored over time 
(scale bar: 100 μm). The macrophages were treated with LPS prior to incorporation (untreated 
macrophages were used as a control). (d) A magnified view of the macrophages within the fibroblast 
tissue over time (scale bar: 50 μm).
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Figure 3.16. (a,b) Macrophage-laden microgels were embedded into a larger hepatocarcinoma tissue 
construct to fabricate multiplex tissue model. The changes in their phenotypes were monitored over 
time (scale bar: 100 μm). The macrophages were treated with LPS prior to incorporation (untreated 
macrophages were used as a control). The arrow indicates the activated macrophages migrating out of 
the microgel. There was a significant decrease in hepatocarcinoma cell density surrounding the 
macrophage (highlighted area). (c) A magnified view of the macrophages within the hepatocarcinoma 
tissue over time (scale bar: 50 μm).
Part IV : Combined effects of co-culture and substrate mechanics on 3D
tumor spheroid formation within microgels prepared via flow-
focusing microfluidic fabrication
Figure 4.1. 1H-NMR spectrum of methacrylic gelatin (MGel). Characteristic peaks (a and b) of 
methacrylate are noted.
Figure 4.2. Schematic illustration of double flow-focusing channel geometry of the microfluidic device 
used to generate cell-laden microgels.
Figure 4.3. (a) Schematic illustration of the fabrication of cell-laden microgels using a “double” flow
focusing microfluidic device. Droplets of gel precursor solution dispersed with tumor cells are photo-
crosslinked to generate the microgels. The cell-laden microgels are continuously cultured to allow the 
cells to proliferate and form spheroids. (b) A microscopic view of the microfluidic device (scale bar: 
200 μm). (c) Representative optical (left) and fluorescent (right) images of cell-laden microgels (scale 
bar: 50 μm). The cells were fluorescently labeled to visualize live (green) and dead (red) cells.
Figure 4.4. (a) Elastic moduli (E) of MGel hydrogels at varying concentrations. (b) The viability of 
MCF-7 cells encapsulated in microgels at varying MGel concentrations, measured at various times up 
to 7 days.
Figure 4.5. Microscopic images of cell-laden microgels at various mechanical stiffness (from C1 to 
C5), controlled by MGel concentration, cultured over time (scale: 50 μm).
Figure 4.6. (a) The number of live MCF-7 cells at various times (Nt) normalized with the initial number 
of live cells (N0) plotted over time. (b) The proliferation rate (k) obtained by fitting the plot in (a) with 
Eq.(1). (*p<0.05, n = 10)
Figure 4.7. The tumor spheroid formation within microgels with varying mechanics after 14 days of 
cell culture (scale: 50 μm). A collection of smaller spheroids was developed within the microgel.
Figure 4.8. (a) Schematic illustration of tumor microenvironment, consisting of multiple types of cells. 
Reprinted with permission from ref.[40]. Copyright 2016 Springer Nature. (b) Optical (left) and 
fluorescent (right) microscopic images of microgels encapsulated with varying amounts of 
macrophages co-cultured with MCF-7 cells (scale bar: 50 um). The cells were fluorescently labeled to 
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visualize live (green) and dead (red) cells.
Figure 4.9. Optical (right) and fluorescent (left) microscopic images of microgels encapsulated with 
varying amounts of fibroblasts co-cultureed with MCF-7 cells (scale bar : 50 μm). The cells were 
fluorescently labeled to visualize live (green) and dead (red) cells.
Figure 4.10. Optical (left) and fluorescent (right) microscopic images of MCF-7 cells and macrophages 
(5:5 ratio) co-encapsulated in the microgels with various mechanical stiffness (from C1 to C5) (scale 
bar: 50 um). The cells were fluorescently labeled to visualize live (green) and dead (red) cells.
Figure 4.11. Immunocytochemical analysis of MCF-7 cells and macrophages encapsulated in microgels 
with varying mechanical properties (from C1 to C5). At various times up to 7 days, E-cadherin (E-cad), 
CD206 and CD80 were fluorescently labeled (scale bar: 50 μm). 4,6’-diamidino-2-phenylindole (DAPI) 
was used to label cell nuclei.
Part V : Cell subtype-dependent generation of breast tumor spheroids within
3D mechanically tunable microgels and their variable responses to 
chemotherapeutics 
Figure 5.1. A representative 1H-NMR spectrum of methacrylic gelatin (MGel). Characteristic 
peaks corresponding to methacrylate are noted (a-c).
Figure 5.2. (a) A flow-focusing microfluidic fabrication of breast tumor cell-laden microgels. (b) Elastic 
moduli (E) of MGel hydrogels at various concentrations. (scale bar: 200 μm)
Figure 5.3. Swelling ratios (Q) of MGel hydrogels with varying rigidity (C1-C5).
Figure 5.4. (a) Optical (right) and fluorescent (left) microscopic images of MDA-MB-231 cells in 
microgels with varying rigidity (C1-C5) (scale bar: 50 μm). (b) The cell viability was quantified as the 
percentage of live cells obtained from (a). (c) The plot of normalized number of live cells (Nt/N0) vs. 
time was fitted with a power-law model to obtain the (d) proliferation rate (kP) (*p<0.05).
Figure 5.5. Fluorescent microscopic visualization of actin (green) and nuclei (blue) of MDA-MB-231 
cells in microgels with varying rigidity over 9 days of culture; (a) C2, (b) C3, and (c) C4 (scale bar: 50 
μm).
Figure 5.6. Fluorescent microscopic visualization of actin (green) and nuclei (blue) of MDA-MB-231 
cells in microgels with varying rigidity over 9 days of culture.
Figure 5.7. Microscopic images of MDA-MB-231 cells cultured on MGel hydrogels with varying 
rigidity (scale bar: 200 um).
Figure 5.8. Microscopic images of (a) MCF-7 and (b) SK-BR-3 cells in microgels with varying rigidity 
(C1-C5) taken at various times up to 21 days (scale bar: 50 μm).
Figure 5.9. Microscopic images of MCF-7 cells cultured on MGel hydrogels with varying rigidity 
(scale bar: 200 um).
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Figure 5.10. Microscopic images of MCF-7 cells cultured on MGel hydrogels with varying rigidity
(scale bar: 200 um).
Figure 5.11. Schematic illustration of spheroid formation mechanisms of MDA-MB-231, MCF-7 and 
SK-BR-3 cells in microgels with varying rigidity (C1-C5).
Figure 5.12. Cytotoxicity of varying concentrations of chemotherapeutic agents, paclitaxel and 
cisplatin, against 2D monolayer cultures of (a, d) MDA-MB-231, (b, e) MCF-7, and (c, f) SK-BR-3 
cells, measured at day 1 and 3 of exposure.
Figure 5.13. Fluorescent imaging of live (green) and dead (red) MDA-MB-231 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 1 day of exposure to different concentrations of (a) 
paclitaxel and (b) cisplatin (scale bar: 50 μm).
Figure 5.14. Fluorescent imaging of live (green) and dead (red) MDA-MB-231 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 3 days of exposure to different concentrations of 
(a) paclitaxel (1nM, 10nM, 50 nM and 100 nM) and (b) cisplatin (30 μM , 100 μM, 300 μM and 500 
μM) (scale bar: 50 μm). (c-f) The cell viability of MDA-MB-231 spheroids in microgels with varying 
rigidity (C2-C5) measured after 1 or 3days of exposure to different concentrations of paclitaxel (50 nM, 
100 nM) and cisplatin (300 μM, 500 μM) (*p<0.05). Solid and dotted lines represent the viabilities of 
monolayer cultures of MDA-MB-231 cells exposed to the same concentration at day 1 and 3, 
respectively.
Figure 5.15. Fluorescent imaging of live (green) and dead (red) MCF-7 cells of spheroids in microgels 
with varying rigidity (C2-C5) taken after 1 day of exposure to different concentrations of (a) paclitaxel 
and (b) cisplatin (scale bar: 50 μm).
Figure 5.16. Fluorescent imaging of live (green) and dead (red) MCF-7 cells of spheroids in microgels 
with varying rigidity (C2-C5) taken after 3 days of exposure to different concentrations of (a) 
paclitaxel (1nM, 10nM, 50 nM and 100 nM) and (b) cisplatin (30 μM , 100 μM, 300 μM and 500 μM)
(scale bar: 50 μm). (c-f) The cell viability of MCF-7 spheroids in microgels with varying rigidity (C2-
C5) exposed to paclitaxel and cisplatin, calculated from (a) and (b) (*p<0.05). Solid and dotted lines 
represent the viabilities of monolayer cultures of MCF-7 cells exposed to the same concentration at day 
1 and 3, respectively.
Figure 5.17. Fluorescent imaging of live (green) and dead (red) SK-BR-3 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 1 day of exposure to different concentrations of (a) 
paclitaxel and (b) cisplatin (scale bar: 50 μm).
Figure 5.18. Fluorescent imaging of live (green) and dead (red) SK-BR-3 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 3 days of exposure to different concentrations of (a) 
paclitaxel (1nM, 10nM, 50 nM and 100 nM) and (b) cisplatin (30 μM , 100 μM, 300 μM and 500 μM) 
(scale bar: 50 μm). (c-f) The cell viability of SK-BR-3 spheroids in microgels with varying rigidity (C2-
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C5) exposed to paclitaxel and cisplatin, calculated from (a) and (b) (*p<0.05). Solid and dotted lines 
represent the viabilities of monolayer cultures of SK-BR-3 cells exposed to the same concentration at 
day 1 and 3, respectively.
Part VI : Facile generation hollow fiber to mimic blood vessel using human
endothelial cells via GelMa and Alginate combination by controlled 
hydrogel stiffness in 3D culture
Figure 6.1. This schematic represents overall experiments. (a) Alginate and MGel mixed Ca2+ as a 
physical cross-linking using Alginate (Semi-IPN) after then chemical cross-linking by UV exposure 
using MGel (IPN). (b) IPN structure can be removed physically cross-linked Alginate by Sodium Citrate. 
(c) Generating of hollow fiber using same methods.
Figure 6.2. (a) and (c) Elastic moduli (E) and Swelling ratios (Q) of Alginate 0.5% and MGel mixed 
Semi-IPN and IPN (b) and (d) Elastic moduli (E) and Swelling ratios (Q) of Alginate 1% and MGel 
mixed Semi-IPN and IPN.
Figure 6.3. SEM images of IPN structure (Alginate 1% and MGel 8%, 10%, 12%, 15%) (scale bar: 
10 μm)
Figure 6.4. Cell viability and proliferation in microgel. Representative microscopic(left) and 
fluorescent (right) images of 3T3 encapsulated in microgel taken at various times up to 7days. The cells 
were fluorescently stained to identify live (green) and dead (red) cells. (a) Semi-IPN structure (b) IPN 
structure (c) and (d) The normalized number of viable cells (Nt/N0) in microgel was measured over time 
(Nt: number of viable cells at time, t, N0: number of initial viable cells) Semi-IPN and IPN. (e) The plot 
in panel (c) and (d) were fitted with a power-law model to obtain the proliferation rate (kP).
Figure 6.5. These images show the process which is removed alginate from IPN microgel in various 
time.
Figure 6.6. Scheme of generation of hollow fiber using alginate and MGel with HUVECs outer phase
and inner phase 0.05M calcium chloride, 10% FBS, 25mM HEPES.
Figure 6.7. (a) Hollow fiber to mimic blood vessel using Alginate and MGel. (b) Microscopic image of 
hollow fiber.
Figure 6.8. Cell viability and proliferation in hollow fiber with HUVECs. Representative 
microscopic(left) and fluorescent (right) images of HUVECs encapsulated in microgel taken at various 
times up to 7days. These images show at 7days. The cells were fluorescently stained to identify live 
(green) and dead (red) cells. (a) Semi-IPN structure (b) IPN structure.
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1.1.1. Theoretical Study of Droplet Generation.
This chapter describes the theoretical background of the droplet formation mechanism using the 
microfluidic flow focusing method as well as the influence of other parameters on droplet generation. 
When two kind of immiscible liquids exposed each other in the microfluidic chip, the liquid breaking 
as a droplet formation via dripping, jetting and squeezing methods. Generally, at slow flow rate, the 
droplet can be made at dripping regime. However, at higher flow rate, the liquid can be divided via thin 
stream which is able to break in order to make droplet formation at jetting regime. And these studies 
can summary in that three kind of method such as dripping, jetting and squeezing.
1.1.1.1. Squeezing
In the squeezing regime case, very low capillary number of continuous phase and disperse phase as 
shown in Figure 1A. In order to maintain the constant flow rate, which increased the pressure apply to 
continuous phase streams. This result said that generating a neck of the dispersed phase of orifice 
channel. Finally, the narrowing neck can be unstable and breaks to droplet formation using disperse 
phase. 1 Droplets are formed at the equilibrium state between interface tension and hydrostatic pressure. 
Gastecki et al. introduced a rate of flow-controlled breakup model using flow focusing microfluidic 
chip at a low flow rate. 1-3 This model describes that the size of droplet is related to the flow rate ratio 
between dispersed phase and continuous phase at low flow rate.
1.1.1.2. Dripping.
In the dripping regime case, two kind of force, one is capillary force, another is viscous drag force, 
can be separated as a droplet formation via flow-focusing microfluidic chip. As shown in Figure 1B, a 
little bit increased the flow rate, the disperse phase can be unstable formation because of minimizing of 
the surface tension force by generated a droplet.4 Continuous phase can overcome surface tension using 
shear force and finally droplet breaks up. Dripping regime examined based on shearing model. In this 
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case, the diameter of droplets is reversely related to the capillary number.
1.1.1.3. Jetting.
In the jetting regime case, there are two kind of method to generate jetting formation. One is Webber 
number (We) of disperse phase fluid is high. Another one is capillary number of the continuous phase 
is high. More detail explained, Weber number of the disperse phase is larger than 1 because of high 
flow rate or high density of disperse phase. In other words, inertia force is dominated rather than 
interfacial tension force. On the other hand, when capillary number of the continuous phase is high 
because of fast flow rate of continuous phase or high viscosity which can occur drag force of the outer 
continuous phase that can over the surface tension force of disperse phased.2 This jetting stream is 
unstable because of unstable and breaking droplet at the downstream of the channel due to surface 
tension of the dispersed phase to minimize the surface area by generating a droplet as shown Figure 1C.
Figure 1.1 Droplet generating method in the flow focusing device. (A) Mode : squeezing regime at 
very low flow rate and low capillary number. (B) Mode : dripping regime at higher flow rate and modest 
capillary number. (C) Mode : jetting regime at high capillary number.
 
1.2. Microfabrication of Microfluidic chip formed Double Flow focusing 
Geometry
  
1.2.1. Microfluidic Chip Design
Figure 1.2 (a) This image is CAD file (b) Fabrication of microfluidic chip using PDMS (c) With 
microfluidic chip and generating droplet.
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As shown the figure 1.2, we choose double flow focusing method in order to cell encapsulated beads 
with high cell viability. All channel width is 150 μm. And the high is 160 μm. 
1.2.2. Mold Fabrication through MEMs Process
Figure 1.3 The process of PDMS microfluidic chip fabrication. 
The fabrication process, as shown in Figure 1.3, begins with a silicon wafer, which is cleaned on the 
surface by pirhana treatment (H2SO4 : H2O2, 10:1) during 10 min. Fully remove the water on the wafer 
surface, coated with a UV-curable SU-8 100 (A). The process involves spin-coating the photoresist to 
control thickness, followed by baking to solidify the SU-8 100. Next, the SU-8 100 coated on the wafer 
and exposed to UV light through a photomask (B), which in the case of the most commonly used 
photoresist, SU-8 100, blocks light from the areas between fluidic channels. The UV exposure results 
in a crosslinking of the polymer’s epoxide moieties and hardening of the exposed polymer regions, 
which remain in place during development in a SU-8 developer, while the unexposed polymer is washed 
off (C). This silicon wafer with hardened polymer features is used as a master mold and is coated with 
a fluorinated silane to aid demolding (D).
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1.2.3. Microchannel Fabrication using PDMS
PDMS, typically mixed at a 10:1 ratio of monomer : curing agent, is poured over the mold to the 
desired height and allowed to polymerize at 60oC for 1 or 2 hours (E). The molded PDMS is removed, 
via holes are punched out, and the device is completed by bonding the PDMS features to a glass slide 
using oxygen plasma treatment (F) of both glass and PDMS (G).
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Tissue Engineering is interdisciplinary field which utilizes cell, biochemical, physical signals and 
biomaterials as well as they combined in order to mimic native tissue.1 The purpose of tissue 
engineering is to offer biological substitutes which can keep, restore and develop the function of 
damaged tissues.2 Tissue engineering applications combined to three kind of pillars : cells, signals and 
scaffolds. These are represented the triad of tissue engineering as shown Figure 2.1.
Figure 2.1. The three kind of part are related to tissue engineering. The combination of cells, signals 
and scaffolds is used to engineer functional tissues.
The scaffolds must be maintained biocompatible with both tissue specific cell types and the desired 
area environment within human body.3 Therefore, it is important that various engineered tissues or 
organs necessitate unique designs and materials. Also, the scaffolds can fabricate with specific 
properties, for example, geometry, pore size, spatial distribution and permeability.4 Artificial tissues 
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would be transplanted into the bodies of patients. The scaffolds are demanded to possess the geometric 
shape of the damaged tissue.5-8 In addition, scaffolds have to provide appropriate mechanical properties 
or stability of shape to resist stresses. Hydrogel, as a scaffold, are usually used for cell encapsulated 
with maintained high biocompatibility and mild gelation conditions.9 Scaffolds are obtained of natural 
or synthetic materials. And they can replicate the functions like natural three-dimensional environment 
in order to proliferate and organize into tissues which can maintain their specialized morphologies.32
Tissue engineering aims to cure diseased or disfunctional tissues and organs. Appropriate sources of 
cells for tissue engineering can be identified. It is also important that finding suitable scaffolds for ECMs 
is challenged.
2.2. ECM Structure and Hydrogel Biomaterials
2.2.1. ECM Structure
Figure 2.2. Complex three-dimensional structure of extracellular matrix (ECM) and ECM-cell 
interactions.
   
These days, some advanced techniques, such as 3D printing and electrospinning, have been improved 
to fabricate scaffolds that can imitate the extra cellular matrix (ECM).10-12 The tissue of the human body 
included extracellular space which molecules are secreted by the cells to form a complex network. 13, 14  
Generally, natural ECM such as collagen, elastin and fibrin consists of two classes of 
biomacromolecules, proteins and glycans.15, 16 ECM proteins are embedded in negatively charged such 
as glycans which containing glycosaminoglycans (GAGs) and proteoglycans (PGs)10, 16-18 GAGs are 
linear polymers of repeated disaccharide derivative with two types, such as sulfated and hyaluronic acid 
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(HA).19 Most ECM proteins, containing collagen, FN(e.g., RGD, REDV and PHSRN), LN(e.g., YIGSR, 
LRE and IKLLI) and elastin(e.g., VAPG) have specific cleavage sites for degradation by enzymes, for 
example, matrix metalloproteinases (MMPs) plasmin and elastase.20-24 MMPs are important role in 
morphogenesis, arthritis, angiogenesis, tumor invasion and metastasis.25 There are two forms of RGD 
peptides, including linear RGD and cyclic RGD (cRGD). The RGD sequence in the cell binding domain 
of FN is exposed at the tip of a loop with a spatial constraint that results in increased affinity for cell 
binding26 as shown Figure 2.2.
2.2.2. ECM property (Mechanotransduction)
Figure 2.3. Stem cells exert forces and they are affected by external forces, which controlled their 
intracellular signaling pathways.27
Stem and cancer cells are interaction mechanically with their local area microenvironment, or niche, 
and these communications lead to develop the processes, direct cell fate, regulate tissue development, 
and are related to the progression of numerous diseases. It is possible that mechanical signals can be 
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used to modify disease progression and directly aid regeneration. There is a sensor called focal adhesion 
on the cell membrane that carries the physical signals from the ECM to the cell nucleus. We called this 
phenomenon ‘mechanotransduction’. Figure 2.3 is well explained how to occur cell to ECM interaction 
through mechanotransduction.
2.2.3. Hydrogel biomaterials
Figure 2.4. Important materials design considerations for tissue engineering, containing cell adhesion 
peptide, protease sensitive peptide for cell mediated matrix degradation, and presence of signaling 
molecules. 
Hydrogel is attractive materials in that biocompatible and achieving mechanically robust networks 
with various enzymes. Various cell-matrix interaction, containing cell adhesion and matrix degradation 
are demanded for cell growth and migration.28 Hybrid hydrogels can be employed to capture these 
properties (Figure 2.4) in a chemically and mechanically versatile substrate. Hydrogels are water-
swollen polymeric materials that can be possible to support three-dimensional structure.
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Figure 2.5 Synthesis hydrogels with good mechanical properties. (A) Topological sliding hydrogel.29
(B) Double network hydrogels composed from two hydrophilic networks.30 (C) Nanocomposite 
hydrogels synthesized by radical polymerization.31
Typical methods of biomaterials synthesis contained crosslinking polymerization using reactive 
polymer precursors. Hydrogels have been three main approaches, introduction of sliding crosslinking 
agent29, double network hydrogels30 and nanocomposite31 hydrogels have noticeable enhanced 
mechanical properties of hydrogels as figure 2.5. Sliding crosslinking agent is a new concept of 
crosslinking. By chemically crosslinking two molecules, a sliding double ring crosslinking agent was 
produced. In this case, the hydrogel has outstanding mechanical properties. Double networks (DN) 
hydrogels are consist of interpenetrating networks (IPNs) formed by two kind of hydrophilic networks. 




1. Berthiaume, F.; Maguire, T. J.; Yarmush, M. L., Tissue engineering and regenerative medicine: history, 
progress, and challenges. Annu Rev Chem Biomol Eng 2011, 2, 403-30.
2. Langer, R.; Vacanti, J. P., Tissue Engineering. SCIENCE 1993, 260.
3. Langer, R., Perspectives and challenges in tissue engineering and regenerative medicine. Adv Mater 
2009, 21 (32-33), 3235-6.
4. Khademhosseini, A.; Langer, R.; Borenstein, J.; Vacanti, J. P., Microscale technologies for tissue 
engineering and biology. PNAS 2005, 103, 2480-2487.
5. Kadler, K., Matrix loading: assembly of extracellular matrix collagen fibrils during embryogenesis. 
Birth Defects Res C Embryo Today 2004, 72 (1), 1-11.
6. Cukierman, E.; Pankov, R.; Stevens, D. R.; Yamada, K. M., Taking Cell-Matrix Adhesions to the 
Third Dimension. SCIENCE 2001, 294.
7. Abbott, A., Cell culture: Biology's new dimension. Nature 2003, 424, 870-872.
8. Lee, G. Y.; Kenny, P. A.; Lee, E. H.; Bissell, M. J., Three-dimensional culture models of normal and 
malignant breast epithelial cells. Nat Methods 2007, 4 (4), 359-65.
9. Nicodemus, G. D.; Bryant, S. J., Cell encapsulation in biodegradable hydrogels for tissue engineering 
applications. Tissue Eng Part B Rev 2008, 14 (2), 149-65.
10. Mi, H.-Y.; Jing, X.; Turng, L.-S., Fabrication of porous synthetic polymer scaffolds for tissue 
engineering. Journal of Cellular Plastics 2014, 51 (2), 165-196.
11. Dutta, R. C.; Dey, M.; Dutta, A. K.; Basu, B., Competent processing techniques for scaffolds in 
tissue engineering. Biotechnol Adv 2017, 35 (2), 240-250.
12. Holzwarth, J. M.; Ma, P. X., Biomimetic nanofibrous scaffolds for bone tissue engineering. 
Biomaterials 2011, 32 (36), 9622-9.
13. Smith, R. L.; Lin, J.; M.C, T.; Shida, J.; Kajiyama, G.; Vu, T.; A.R, H.; M.C, v. d. M.; Goodman, S. 
B.; Schurman, D. J.; D.R, C., Time-dependent effects of intermittent hydrostatic pressure on articular c 
on rocyte type II collagen and aggrecan mRNA expression. J Rehabil Res Dev. 2000, 37, 153-61.
14. Lee, J. H.; Fitzgerald, J. B.; Dimicco, M. A.; Grodzinsky, A. J., Mechanical injury of cartilage 
explants causes specific time-dependent changes in chondrocyte gene expression. Arthritis Rheum 2005,
52 (8), 2386-95.
15. Gailit, J.; Clark, R. A., Wound repair in the context of exratcellular matrix. Curr Opin Cell Biol. 
1994, 6, 717-25.
16. Scott, J. E., Extracellular matrix, supramolecular organisation and shape. J Anat. 1995, 187, 259-
269.
17. Papagiannopoulos, A.; Waigh, T. A.; Hardingham, T. E., The viscoelasticity of self-assembled 
proteoglycan combs. Faraday Discuss 2008, 139, 337-57; discussion 399-417, 419-20.
25
18. Rhodes, J. M.; Simons, M., The extracellular matrix and blood vessel formation: not just a scaffold. 
J Cell Mol Med 2007, 11 (2), 176-205.
19. Dudhia, J., Aggrecan, aging and assembly in articular cartilage. Cell Mol Life Sci 2005, 62 (19-20), 
2241-56.
20. Ogura, Y.; Matsunaga, Y.; Nishiyama, T.; Amano, S., Plasmin induces degradation and dysfunction 
of laminin 332 (laminin 5) and impaired assembly of basement membrane at the dermal-epidermal 
junction. Br J Dermatol 2008, 159 (1), 49-60.
21. Mydel, P.; Shipley, J. M.; Adair-Kirk, T. L.; Kelley, D. G.; Broekelmann, T. J.; Mecham, R. P.; 
Senior, R. M., Neutrophil elastase cleaves laminin-332 (laminin-5) generating peptides that are 
chemotactic for neutrophils. J Biol Chem 2008, 283 (15), 9513-22.
22. Chang, C.; Werb, Z., The many faces of metalloproteases: cell growth, invasion, angiogenesis and 
metastasis. TRENDS in Cell Biology 11, S37-S43.
23. Giannelli, G.; Falk-Marzillier, J.; Schiraldi, O.; Stetler-Stevenson, W. G.; Quaranta, V., Induction of 
Cell Migration by Matrix Metalloprotease–2 Cleavage of Laminin-5. SCIENCE 1997, 277.
24. Seiki, M., The cell surface: the stage for matrix metalloproteinase regulation of migration. Current 
Opinion in Cell Biology 2002, 14, 624-632.
25. Amano, S.; Akutsu, N.; Matsunaga, Y.; Nishiyama, T.; Champliaud, M. F.; Burgeson, R. E.; Adachi, 
E., Importance of balance between extracellular matrix synthesis and degradation in basement 
membrane formation. Exp Cell Res 2001, 271 (2), 249-62.
26. Leahy, D. J.; Aukhil, I.; Erickson, H. P., 2.0 A˚ Crystal Structure of a Four-Domain Segment of 
Human Fibronectin Encompassing the RGD Loop and Synergy Region. Cell 1996, 84, 155-164.
27. Vining, K. H.; Mooney, D. J., Mechanical forces direct stem cell behaviour in development and 
regeneration. Nat Rev Mol Cell Biol 2017, 18 (12), 728-742.
28. Lau, H. K.; Kiick, K. L., Opportunities for multicomponent hybrid hydrogels in biomedical 
applications. Biomacromolecules 2015, 16 (1), 28-42.
29. Okumura, Y.; Ito, K., The Polyrotaxane Gel: A Topological Gel by Figure-of-Eight Cross-links. Adv 
Mater 2001, 13.
30. Gong, J. P.; Katsuyama, Y.; Kurokawa, T.; Osada, Y., Double-Network Hydrogels with Extremely 
High Mechanical Strength. Advanced Materials 2003, 15 (14), 1155-1158.
31. Haraguchi, K.; Takehisa, T., Nanocomposite Hydrogels: A Unique Organic-Inorganic Network 
Structure with Extraordinary Mechanical, Optical, and Swelling/De-swelling Properties. Adv Mater 
2002, 14.




Microfluidics-assisted fabrication of macrophage 
microtissues with tunable physical properties for 
developing in vitro multiplex tissue model
3.1. Introduction
There is a growing need to develop physiologically relevant and tunable tissue models for fundamental 
investigation of both normal and disease physiology as well as drug screening applications.1-3 For this 
purpose, various tissue engineering approaches are being developed and applied to fabricate 
biocompatible materials with tunable physical and biological properties as scaffolds for culturing cells 
and tissue for desired outcomes.1-5 This research trend is largely influenced by the ethical issues 
surrounding the use of animal models.6 In addition, the variability and questionable efficacy of animal 
models for predicting human outcome have also accentuated the need for engineering more 
reproducible and scalable platforms mimicking human tissues.1-3 Therefore, microfabrication 
technology such as lithography and deposition printing is utilized to develop more complex and 
physiologically relevant in vitro tissue models to account for the heterogeneous nature of a biological 
tissue.7-10 In addition, a high-throughput technology such as microarray is applied to create multiplex 
tissue platforms for efficient multiple analyses.11, 12 In recent years, microfluidics technology has 
provided a valuable platform for engineering a miniaturized tissue models. For example, “organ-on-a-
chip” technology is being heavily investigated, in which small tissues are cultured within a microfluidic 
chip, mostly made from biocompatible elastomers, and their biochemical analyses are efficiently 
analyzed, often in situ.13-15 The fluid channels and tissue chambers within a microfluidic chip can be 
designed to mimic the complexities of a natural tissue environment, with multiple analytical methods 
embedded in a single chip platform. Alternatively, microfluidics is also being utilized to develop 
emulsion particles (“droplets”) with varying size and shape in micrometer scale resolutions for 
biomedical applications.16-19 Large quantities of monodisperse droplets can be efficiently fabricated and 
embedded with biological molecules (e.g. genes and proteins) and cells for high-throughput 
screening and injectable delivery applications. The droplets can be further engineered to 
generate microgels by crosslinking the droplets consisting of gel-forming precursors, which 
further diversifies the material properties.20-24 Inspired by the versatility of the microfluidics 
approach, we have adopted the droplet microfluidic technology to create microgels with varying 
mechanical properties for use as 3D cell culture platform. Using a microfluidic double flow-focusing 
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device, monodisperse droplets of photo-crosslinkable gelatin containing cells in the core region were 
generated and crosslinked to develop cell-laden microgels with high viability. There have been several 
previous studies using microfluidics assisted fabrication of cell-laden microgels.21, 25, 26 Most of these 
studies, however, do not take into account the effect of material properties. Herein, the mechanical 
properties of the microgels were controlled by varying the concentration of gel-forming macromer. 
Using macrophage as a model cell system, which is well known to undergo proliferation as well as M1 
(inflammatory) / M2 (resolving) polarization in response to chemical and biophysical stimuli from the 
surrounding, the macrophages were encapsulated in microgels having various mechanical rigidity, and 
its effect on their viability, proliferation, and differentiation was evaluated.27-30 Ultimately, these 
macrophage ‘microtissues’ were then dispersed and incorporated into a larger tissue construct consisting 
of different cell types to develop a hydrogel-based 3D co-culture model. Most co-culture studies involve 
either a platform with a permeable membrane to allow paracrine effects or simple cell mixtures,31 which 
do not represent a real tissue environment in which different cell types reside in separate but interactive 
3D microenvironments. This “multiplex” tissue model allowed the monitoring of complex interactions 
between two different types of cells residing in adjacent, compartmentalized areas within a tissue. Using 
this model, the phenotypical changes of macrophages in microgels and the surrounding cells, either 
cancer cells or fibroblasts, based on the mutual interaction were monitored and analyzed.
3.2. Material and methods
3.2.1. Fabrication of silicon master
The standard photolithography was utilized to fabricate the silicon master for polydimethylsiloxane
(PDMS)-based microfluidic device. Briefly, SU-8 2000 (MicroChem Corp.) was spin-coated on a 
silicon wafer (STC, Japan) and then bake at 95oC to remove the solvent and harden the photoresist. A 
photomask with patterns for the microfluidic channels was placed on top of the wafer, and exposed to 
UV to cross-link the patterned area. After baking at 95 °C to further solidify the cross-linked photoresist, 
the wafer was cooled to room temperature, and placed in SU-8 developer to remove the unexposed 
photoresist. The wafer was then rinsed with isopropanol three times and dried. The schematic 
illustration of the silicon master is shown in Figure 3.1.
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Figure 3.1. Schematics of the microfluidic device with double flow-focusing channel geometry to 
develop cell-laden microgels.
3.2.2. Fabrication of PDMS microfluidic flow-focusing device
PDMS elastomer was fabricated on top of the silicon master, by placing the mixture of silicone 
elastomer base and the curing agent (base: curing agent = 10:1, Sylgard®184 Silicone Elastomer Kit) 
on the master, degassing the PDMS mixture in a vacuum desiccator for 1 hour, and curing for 3 hours 
at 80 °C. Then, the PDMS elastomer with engraved microchannels was detached from the master, and 
fluid inlets and outlets were created using a hole punch (0.5 mm diameter). Finally, a glass slide was 
irreversibly bonded to the PDMS by treating their surfaces with oxygen plasma for 30 seconds to 
fabricate the PDMS microfluidic device.
3.2.3. Determination of droplet concentrations
The droplets obtained by a microfluidic double flow-focusing device consisted of core and shell 
regions at different concentrations. The overall concentration of the droplet after the core and shell 
regions merged was estimated by relative sizes of core and shell regions of a droplet. Briefly, the 
microscopic image was taken after the droplet was formed, which showed the clear demarcation 
between the core and shell regions before merging. The volumes of the core (Vc) and the shell (Vs) was 
calculated, and their relative portions were used to calculate the overall concentration (CT),
VT was the total droplet volume, Cc and Cs were the concentrations of core and shell, respectively, and 
rc was the radius of the core. In this double microfluidic flow-focusing geometry, the average Vc/V and 
Vs/V were 0.52 and 0.48. The concentrations for C1, C2 and C3 are calculated as follows.
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Table 3.1 Overall concentration of calculated MGel at C1, C2 and C3.
3.2.4. Synthesis of photo-crosslinkable gelatin
Conjugation of methacrylic functional group to gelatin (i.e. methacrylic gelatin (MGel)) was 
accomplished following a previously published report. Briefly, gelatin (10 g, from porcine skin, Sigma 
Aldrich), 4-dimethylaminopyridine (1g, Sigma Aldrich), and 4-methoxyphenol (0.1g, Sigma Aldrich) 
were first dissolved in 100mL dimethyl sulfoxide at 50 °C. Glycidyl methacrylate (4 mL, Sigma Aldrich) 
was slowly added to the mixture, and the reaction was continued for 48 hours at 50 °C under N2. The 
mixture was extensively dialysis against deionized water and lyophilized to obtain the final product. 
The chemical structure of methacrylate on gelatin was confirmed by 1H-NMR (400-MR DD2, Agilent) 
Figure 3.2.
3.2.5. Mechanical properties of hydrogels
MGel precursor solutions at various concentrations, from 6 to 14 % (w/v), with 0.2 % (w/v) Irgacure 
2959 as a photo-initiator in PBS were prepared. Each solution was placed in a thin glass mold (1 mm 
spacing) and irradiated with UV for 2 minutes (intensity: 200mW, distance: 5 cm, Model S1500, 
Omnicure®) to fabricate the hydrogel. Hydrogel disks were punched out (8 mm diameter) and incubated 
in PBS overnight before mechanical characterization. The mechanical properties of MGel hydrogels 
were assessed by measuring elastic moduli from uniaxial compression tests (Model 3343, Instron). Each 
hydrogel disk was compressed at a fixed rate (1 mm min-1.), and a stress-strain relationship was obtained. 
The elastic modulus was calculated as the slope of the stress-strain curve at the region of elasticity (i.e. 
initial 10 % strain).
3.2.6. Fabrication of cell-laden microgels
The concentrations of MGel in the primary (Aq1) and secondary (Aq2) aqueous were 7 and 10, 9 and 
12, and 11 and 14 % (w/v), respectively. The concentration of Aq2 which becomes the outer layer of 
the droplet was kept higher than that of Aq1, in order to minimize the Aq1 with cells in the core from 
moving outward via diffusion. The macrophage (RAW264.7 cell line purchased from ATCC®) cells 
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were dispersed in the Aq1 at 1 × 107 cells mL-1. Both Aq1 and Aq2 contained 0.2 % (w/v) Irgacure 
2959® as a photo initiator. Mineral oil supplemented with 20 % (v/v) Span80 (Sigma Aldrich) was used 
as the oil phase (O). The fluids were injected into the microfluidic device in controlled rates via 
electronic pumps (Legato®100, KD Scientific). To control the size of the droplets, the flow rate of Aq 
was varied from 80 to 150 μL hr-1, while keeping the flow rate of O at 500 μL hr-1. The droplets generated 
from the microfluidic device was exposed to UV for 2 minutes (intensity: 200mW, distance: 5 cm, 
Model S1500, Omnicure®) to crosslink the droplets to form microgels. The collected cell-laden 
microgels were incubated in the cell culture media (Dulbecco’s Modified Eagle Medium supplemented 
with 10 % fetal bovine serum and 1 % penicillin/streptomycin, all purchased from Thermo Fisher) at 
37 °C under 5 % atmospheric CO2. 
Figure 3.2 1H-NMR spectra of (a) MGel and (b) degraded MGel hydrogel. The methacrylic peaks (a, 
b) disappeared after gelation.
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3.2.7. Fabrication of in vitro multi-tissue model
The microgel-based macrophage tissues were embedded into a larger tissue construct consisting of 
different types of cells to fabricate in vitro multi-tissue model. The macrophage-laden microgels were 
suspended in a precursor solution consisting of cells with the density of 1 x 106 cells mL-1 dispersed in 
8 % (w/v) MGel and 0.2 % (w/v) Irgacure 2959®. The solution was placed in a thin glass mold (0.5 
mm spacing) and irradiated with UV for 2 minutes (intensity: 200 W, distance: 5 cm, Model S1500, 
Omnicure®) to develop the multi-tissue construct. The cell types used for the large tissue constructs 
were fibroblasts (NIH-3T3), hepatocarcinoma (HepG2) all purchased from ATCC®.
3.2.8. In vitro evaluation
The viability of cells encapsulated in the microgels was measured using LIVE/DEAD Cell Viability 
Assay (Thermo Fisher). Briefly, microgel samples at designated time points were taken and treated with 
calcein AM and ethidium homodimer-1 to fluorescently label live (green) and dead (red) cells, 
respectively. The cells were visualized under an inverted fluorescent microscope (XDS-3FL, Optika), 
and the numbers of live and dead cells were counted. The viability was reported as the percentage of 
live cells. For each condition, the average value of viability results in 15 microgels was reported. To 
induce differentiation of the macrophages in microgels, they were treated with lipopolysaccharide (LPS, 
1 μg mL-1, Sigma Aldrich) included in the cell culture medium. The medium was replenished every two 
days. The change in cellular morphology over time was monitored with the microscope. To visualize 
the change in biomarkers of macrophage cells undergoing differentiation, immunofluorescent labeling 
of the characteristic protein markers (e.g. CD80 for M1 phenotype and CD206 for M2 phenotype) was 
performed. Hamster anti-mouse CD80 and rat anti-mouse CD206 were used as primary antibodies 
(1:250 dilution). AlexaFluor568-linked anti-hamster IgG and AlexaFluor488-linked goat anti-rat IgG 
were used as secondary antibodies for the hamster anti-mouse CD80 and rat anti-mouse CD206 
antibodies, respectively (1:250 dilution). 4',6-diamidino-2-phenylindole (DAPI, 100 ng mL-1, Sigma 
Aldrich) was also used in conjunction to stain the nuclei. After staining, the fluorescent images of the 
cells within the microgels were then visualized using a confocal microscope (FV1000, Olympus)
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Figure 3.3 (a) Schematic illustration of a double flow-focusing microfluidic fabrication of macrophage-
laden microgels. (b) Elastic moduli (E) and swelling ratios (Q) of photo-crosslinked MGel hydrogels at 
various concentrations.
3.3. Results and Discussion
3.3.1. Fabrication of macrophage-laden microgels
In this study, a microfluidic device having a flow-focusing geometry was used to generate cell-laden 
microgels. It allows the formation of monodisperse droplets of gel precursor solution infused with cells, 
after which photo-crosslinking scheme was employed to generate cell-laden microgels (Figure 3.3a). 
This particular “double” flow-focusing microfluidic device was chosen, based on our previous study, 
because it allows the generation of droplets with core-shell morphology, with cells being mostly in the 
core region, to enhance the biocompatibility of the droplet and subsequent microgel fabrication.21, 26 In 
this device, the cells included in the primary aqueous phase (‘Aq1’) could be directed to the core region 
of the droplet, surrounded by the secondary aqueous phase (‘Aq2’) making up the shell region which 
acted as a buffering zone against the surrounding continuous oil phase (O) which is known to cause 
cytotoxic effects.21, 32 To further enhance the biocompatibility, the concentration of methacrylic gelatin 
(MGel) in Aq2 was kept higher than that of Aq1, so initially the outer shell of Aq2 would have higher 
viscosity than the inner core of Aq1, and then it would make the cells in the core more difficult to move 
toward the shell having higher viscosity. This experiment design thereby increased the likelihood of 
maintaining the cells within Aq1. Initially, there was a noticeable delineation between core and shell 
regions of a droplet, as expected. But the core and shell regions of the droplet eventually merged over 
time via diffusion.(Figure 3.4) More significantly, even after the droplet formation, the cells mostly 
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stayed within the core region, demonstrating the effectiveness of this design, because the polymer 
chains moving into the core region have greater effect on keeping the cells within the core region, as 
compared with the water moving out to the shell region pushing the cells out. The extent of the photo-
crosslinking reaction was also determined by the characteristic methacrylic peaks of MGel in 1H-NMR 
spectra, which disappeared after gelation, demonstrating that the photo-crosslinking reaction went to 
completion. (Figure 3.2)
3.3.2. Physical properties of microgels
The mechanical properties of the microgels could be conveniently controlled by the concentration of 
MGel. Here, three different sets of concentrations for Aq1 and Aq2 were tested; 7 % and 10 % (‘C1’), 
9 % and 12 % (‘C2’), and 11 % and 14 % (‘C3’). Due to the difficulty of directly measuring the 
mechanical properties of the microgels, larger MGel hydrogels at varying concentrations were 
separately fabricated using the same photo-crosslinking scheme and their elastic moduli were obtained 
by uniaxial compression. Since two aqueous solutions with different concentrations (e.g. Aq1 and Aq2) 
were used to develop the microgels, the overall concentration of the microgels was estimated by the 
relative amounts of Aq1 and Aq2 making up to core and shell regions of the microgels, which was 
determined from the microscopic image taken during the droplet formation.
Figure 3.4 A microscopic image of a cell-encapsulated droplet showing a distinct core-shell interface 
right after formation(left). The border between core and shell, identified with arrows, disappear soon 
after, and the droplet become homogeneous (from left to right). (b) Microscopic images of cell-laden 
microgels fabricated before core-shell regions of the droplets merged. The interface between core and 
shell regions are clearly shown. (scale bar: 50 μm)
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The volume ratio of Aq1 and Aq2 was determined to be 52:48, and thus the overall concentrations of 
C1, C2, and C3 were 8.4 %, 10.4 %, and 12.4 %, respectively. The elastic moduli at those concentrations 
were 1.8, 10.2, and 18.5 kPa, for C1, C2 and C3, respectively. (Figure 3.3(b), Table 3.2) The trend in 
swelling ratio was opposite to that of elastic modulus, as expected, since the porosity within the 
hydrogel becomes reduced with increasing crosslinking density. The size of the microgels could also be 
controlled by the ratio of flow rates of Aq and O (QAq/QO) during the droplet formation (Figure 3.5(a), 
Figure 3.6)  
Figure 3.5. (a) Control of droplet diameters by ratios of aqueous-to-oil flow rates (QAq/QO). (b) Phase 
contrast and fluorescent images of macrophage-laden microgels with varying size. (c) The viability of 
cells encapsulated in microgels with varying size (scale bar: 50 μm) at day 1. D1=100 μm, D2=120 μm, 
D3=160 μm, D4=200 μm.
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Table 3.2 Stress-strain curves of MGel hydrogels at various concentrations obtained by uniaxial 
compression. The table lists the average elastic moduli (E) of MGel hydrogels calculated from the 
curves.
Figure 3.6 Microfluidic generation of gel-precursor droplets at varying ratios of aqueous-to-oil flow 
rates (QAq/QO). (a) QAq/QO = 0.095, (b) QAq/QO = 0.21, (c) QAq/QO = 0.32, (d) QAq/QO = 0.45 (scale bar: 
200 μm).
Due to the increasing viscosity of Aq phases with MGel concentration, the range of microgel diameter 
controlled under the given QAq/QO became higher with degreasing MGel concentration. In this 
microfluidic channel dimensions, the diameter could be controlled from 80 to 165 um. It is suggested 
that larger microgels could be generated from a microfluidic device with larger channel dimensions. On 
the other hand, the droplets smaller than the lower limit could not be pinched off at lower QAq/QO due 
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to the high viscosity of Aq phase opposing smaller droplet formation. After the microgel was immersed 
in buffered formation, there was approximately 20 % increase diameter for all microgel conditions due 
to swelling behavior of the microgels, as expected.
3.3.3. Biocompatibility of macrophage-laden microgels
3.3.3.1. Effect of microgel size
The biocompatibility of the microfluidic process to fabricate microgels and the microenvironment of 
the microgels as a 3D cell culture platform was assessed by measuring the viability and proliferation of 
the encapsulated cells over time. The viability here was defined as the percentage of live cells at a given 
time point. First, the effect of microgel size was evaluated by measuring the viability at microgels with 
four different diameters, 100 μm (‘D1’), 120 μm (‘D2’), 160 μm (‘D3’), and 200 μm (‘D4’), while 
keeping the concentration constant at C2. First, the viability of cells encapsulated in droplets prior to 
the photo-crosslinking step was measured, which showed that the cell viability was well maintained, 
demonstrating the biocompatibility of the microfluidic process to generate droplets. (Figure 3.7) After 
photo-crosslinking to synthesize cell-laden microgels, the initial viability of cells in microgels measured 
at day 1 also revealed that the viability remained high, above 80%, for all conditions. However, the 
viability was higher at larger microgels to a small degree (e.g. 90 % for D3 and D4, 85 % for D2, and 
80 % for D1). (Figure 3.5(b), (c)) At lower QAq/QO to generate smaller droplets, the pinch-off occurred 
more immediately with less jetting, and as a result, the core-shell regions became less clearly defined 
and the shell was thinner. (Figure 3.6) This result likely led to the greater likelihood of cells exposed to 
the oil phase during the pinch-off to form the smaller droplet formation. It is also possible that the 
harmful effect of UV irradiation became more pronounced for the cells in smaller droplets due to greater 
extent of UV penetration. In any case, the viability was above 80 % for all conditions, indicating the 
microfluidic process to generate droplets as well as photo-crosslinking step. Further cell culture up to 3 
days resulted in the proliferation of the encapsulated cells with high viability for all conditions, which 
further demonstrated the biocompatibility of the microgels regardless of the size of microgels (Figure 
3.10)
3.3.3.2. Effect of microgel mechanics
It is well established that the mechanical cues imparted by the surrounding matrices exert significant 
effects on residing cells by sigmal transduction through focal adhesion.33 Therefore, it was hypothesized 
that the mechanical properties of the microgels, controlled by the concentration of MGel, would 
influence the macrophage activities. The viability of macrophage cells encapsulated within the 
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microgels having different rigidity was assessed at various time points (Figure 3.8(a), Figure 3.7).
Figure 3.7 The viability of cells encapsulated in droplets having various sizes measured before photo-
crosslinking to develop cell-laden microgels. D1=100 μm, D2=120 μm, D3=160μm, D4=200 μm. (scale 
bar: 50 μm)
The size of the microgel was fixed at 120 μm diameter. The initial viability, taken at day 1, was the 
highest at 85 % at the lowest MGel concentration (C1), and decreased to a small degree with increasing 
concentration (e.g. 77 % at C2, 72 % at C3) (Figure 3.8(b)). It was estimated that it was due to an 
increased level of radicals within the microgels during the gelation with greater amounts of reactants.
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Figure 3.8 Cell viability and proliferation in microgels at C2 (Aq1/Aq2=9%/12%) (a) Microscopic 
(upper) and fluorescent (lower) images of macrophages encapsulated in microgels taken at various 
times. The cells were fluorescently stained to identify live (green) and dead (red) cells (scale bar: 50 
μm). (b) viability of macrophages at various times during culture up to 7 days. (c) The normalized 
number of viable cells (Nt/N0) in the microgels was measured over time. (d) The plot in (c) was fitted 
with a power-law model to obtain the proliferation rates (kP) (*p<0.05).
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Figure 3.9 Cell viability and proliferation in microgels at (a) C1 (Aq1/Aq2 = 7% / 10%) and (b) 
C3(Aq1/Aq2 = 11% / 14%). Microscopic (upper) and fluorescent (lower) images of macrophages 
encapsulated in microgels taken at various times. The cells were fluorescently stained to identify live 
(green) and dead (red) cells (scale bar: 50 μm).
Nonetheless, the cells within the microgels at all conditions proliferated and formed high-density cell 
spheroids within the structure during the seven days of culture. The significant increase in the number 
of live cells, coupled with low number of dead cells, signified the biocompatibility of the microgels. It 
is interesting to note that the size of spheroids increased dramatically over the course of culture that 
they occupied the majority of the microgel, but the microgel itself did not expand nor fractured by 
increased internal pressure. This result further demonstrated the cells were able to significantly remodel 
the inner environment of the microgels to accommodate the increased cell density. This was made 
possible because the microgel consisted of crosslinked network of gelatin, which is derived from natural 
collagen and retains cell responsive moieties such as RGD peptide and MMP recognition domains.34, 35
The macrophage cells used in this study have been shonw to express MMPs.36 Hydrogels made from 
synthetic polymers, on the other hand, generally are not conducive towards this level of remodeling. 
The proliferation rate of macrophages in microgels at various MGel concentrations were calculated to 
assess the effect of mechanical properties on the encapsulated cells (Figure 3.8(c)). The increase in 
number of live cells (Nt/N0) were counted at different times up to 5 days, after which it was not feasible 
to due to many overlaps (Figure 3.8(c)). The proliferation rate (kP) was obtained by fitting the plot with 
a power-law model (Figure 3.8(d)). Interestingly, the kP was significantly larger at C2 than both C1 and 
C3, suggesting there was an optimal mechanical environment for the encapsulated cells for proliferation. 
The increase in kP from C1 to C2 indicated that increased rigidity of the microgel had a significant 
impact on improving the proliferation of cells in 3D environment. However, further increase in MGel 
concentration from C2 to C3 resulted in diminished kP, though it was still larger than that at C1. This 
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could be a result of diminished permeability of the microgels with increased crosslinking density. 
Similar combined effects of mechanical and diffusional properties of hydrogels on the cells in 3D 
environment have been previously demonstrated.21, 37 To evaluate the effect of different cell culture 
dimensions (2D vs. 3D), the same macrophage cells were separately cultured on the surface of MGel 
hydrogels at varying concentrations, and their proliferation behavior was measured and compared with 
that as shown above (Figure 3.13). Interestingly, initial cell adhesion was more pronounced at lower 
rigidity.38
Figure 3.10 The viability of cells encapsulated in microgels with varying size at day 3 (scale bar: 50 
μm). D1=100 μm, D2=120 μm, D3=160 μm, D4=200 μm.
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Figure 3.11 (a) Differentiation of macrophages in microgels. (a) Microscopic images of macrophages 
in different microgels treated with LPS at day 7 (scale bar: 50 μm). Differentiated cells demonstrate 
sprouting formation. (b) The viability of macrophages at various times during culture up to 7 days. (c) 
The percentage of differentiated macrophages in the microgel.
3.3.4. Induction of macrophage differentiation in microgels
The macrophages can be classified into M1 and M2 phenotypes, depending on their physiological 
functions.27-30 Generally, M1 macrophages promote inflammatory response, whereas M2 macrophages 
promote tissue repair, as identified by their different cytokine expression profiles and morphologies. 
M1/M2 transition (‘Mϕ polarization’) is stimulated by various cytokines produced from surrounding 
tissue in response to physiological changes such as tumor, inflammation and wound healing, or from 
microbial toxins such as lipopolysaccharide (LPS). Therefore, the effect of mechanical properties of 
microgels on the differentiation of encapsulated macrophages undergoing Mϕ polarization, the cell-
laden microgels were exposed to LPS during the culture, and their morphological transformation was 
monitored (Figure 3.11, Figure 3.12).
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Figure 3.12 Microscopic images of macrophage encapsulated in MGel microgels at varying
concentrations (C1, C2 and C3) treated with LPS to induce Mϕ polarization (scale bar: 50 μm).
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Figure 3.13 Microscopic images of macrophage cells cultured on the surfaces of MGel hydrogels at 
varying concentrations (C1, C2, and C3) which were prepared separately to assess the effects of culture 
conditions (2D vs. 3D) on the macrophage proliferation (scale bar: 200 μm). The initial cell adhesion 
and proliferation were monitored over time.
Previous studies have shown that the macrophage cell type used in this study (RAW264.7) 
demonstrates dendritic morphology, with increased expression of cell surface markers associated with 
M1 phenotype (e.g. CD80, CD86) as opposed to M2 phenotype (e.g. CD206, CD163).39, 40 The 
mechanical properties of microgels were controlled with MGel concentrations; C1, C2 and C3. With 
the induction by LPS, the level of proliferation on all conditions diminished over time as compared to 
normal culture conditions as shown in Figure 3.8, as the number of cells did not significantly increase 
after 3 days, while maintaining their viability Figure 3.11(b), Figure 3.12. The cells demonstrating 
“dendrite”-like morphology (i.e. filopodial projections), began to appear soon after, and the number of 
differentiated cells reached maximum around day 7 of culture Figure 3.11(a). The macrophage cells 
acquiring filopodia, a hallmark of cellular migration, in response to LPS have been demonstrated.41-44
The number of differentiated cells was highest at C2 in which over 60 % of the cells residing in the 
microgels showed filopodial projections Figure 3.11(c). On the other hand, the degrees of differentiation 
at other conditions were remarkably low, especially at C1 (> 7 %). This result demonstrated that the 
mechanical properties of the microgels had significant influence over the LPS-induced activation of the 
encapsulated macrophages. This type of biphasic trend was similar to the macrophage proliferation in 
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Figure 3.8. In regards to previous studies, in which macrophage proliferation and LPS-induced 
activation were promoted by the rigidity of substrate for 2D culture, the result shown here also showed 
the positive effect of increased rigidity on the encapsulated macrophages from C1 to C2.45 However, 
the effect of diffusion likely came into play with 3D culture, as extensively reduced permeability of the 
microgel at higher stiffness (at C3) meant limited inner space to allow the cellular growth as well as 
cell spreading to take place.
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Figure 3.14 Immunocytochemical analysis of macrophage-laden microgels at different mechanical 
properties: (a) C1, (b) C2, (c) C3. The cells were treated with LPS to induce Mϕ polarization. At various 
time points, the characteristic cell surface markers, CD80 (red) and CD206 (green), on the cells 
encapsulated in the microgels were fluorescently labeled and monitored (scale bar: 50 μm). DAPI was 
used to label cell nuclei (blue).
Immuno-cytochemical analysis of the LPS-induced activation of encapsulated macrophages was 
performed to further characterize the different levels of activation in response to varying mechanical 
properties of the microgels Figure 3.14. The cellular expressions of CD80 and CD206, which are known 
to be characteristic biomarkers for M1 and M2 phenotypes, respectively, were monitored over the 
duration of cell culture. The levels of expressions were compared with those from untreated cells as a 
negative control. Also, the effect of mechanical properties of the microgels (e.g. C1, C2, and C3) on the 
biomarker expression was also explored. For untreated cells within the microgels, the expressions of 
CD80 and CD206 did not significantly change over time, maintaining their initial basal levels at day 1, 
at the highest microgel rigidity (at C3) Figure 3.14(b) and 3.14(c). However, at C1 and C2, there was 
noticeable increase in CD206 expression over time, while simultaneously showing decrease in CD80, 
suggesting the polarization favored M2 even without external stimuli at lower mechanical rigidity of 
the microgel Figure 3.14(a). This result indicated that the cells without any external stimuli did not 
show preferential polarization at higher substrate rigidity, but at lower rigidity the cells increased their 
anti-inflammatory potential. For the cells treated with LPS to induce M1 polarization, the level of CD80 
expression correlated well with the number of cells undergoing morphological changes shown in Figure 
3.11. The CD80 expression increased significantly over time and much greater than the untreated cells 
at C2, with simultaneous decrease in CD206 expression Figure 3.14(b). Similar expression profiles 
were shown for C3, though to a lesser extent Figure 3.14(c). For C1, the increase in CD80 expression 
was not as apparent as in other microgel conditions, similarly demonstrated by the lack of 
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morphological change, but the decrease in CD206 expression over time was more clearly demonstrated 
Figure 3.14(a). Taken together, the expressions of cellular markers for M1/M2 polarization of the 
macrophages encapsulated in microgels in response to LPS closely correlated with the morphological 
changes of the cells. Furthermore, the LPS induction of the encapsulated cells for M1 polarization was 
largely influenced by the mechanical properties of the microgels, highlighting the importance of tuning 
the substrate properties for desired phenotype.
3.3.5. In vitro multiplex tissue model
In recent years, considerable research efforts are being made to engineer in vitro tissue models to 
replace animal models for ethical concern over animal usage as well as creating more scalable, 
reproducible, and controllable testing platform.7-10 Therefore, various tissue engineering approaches are 
adopted for this purpose, but it is still a substantial challenge to recreate more complex 
microenvironment consisting of multiple cell types. Herein, the macrophage-laden microgels developed 
in this study were incorporated into a larger hydrogel-based tissue constructs to fabricate a “multiplex” 
tissue model consisting of different cell types tissues. Due to their miniature size, the microgel-based 
tissue constructs could be viewed as dispersible and injectable tissue units capable of being incorporated 
into other tissue models. In addition, compared to conventional co-culture systems such as semi-
permeable separating membrane and a simple cell mixture, in which a given culture condition (e.g. 
medium compositions, substrate properties) applies to all cell types, the microgel conditions could be 
controlled to optimize the encapsulated cells separate from other constituting cell types to fabricate 
more complex tissues. Using this in vitro tissue model, the effect of mutual interaction between 
macrophage and surrounding cells on the changes in their behavior were explored.
3.3.5.1. Fibroblast tissue
Previous studies using various co-culture systems have demonstrated that fibroblast activities are 
heavily influenced by various cytokines produced by macrophages in different physiological states. For 
example, during inflammation macrophages express pro-inflammatory cytokines (e.g. interleukin (IL)-
1, 6, 12, tumor necrosis factor (TNF)-α, macrophage colony stimulating factor (M-CSF)) which induce 
proliferation and migration of fibroblasts. On the other hand, the macrophages are also able to influence 
fibroblasts to express extracellular matrix components during wound healing process by releasing 
growth factors such as FGF, platelet-derived growth factor (PDGF) and transforming growth factor 
(TGF)-β1. Therefore, macrophage-laden microgels were first incorporated into larger fibroblast-laden 
tissue constructs to monitor their phenotypical changes Figure 3.15(a). The macrophages were treated 
with LPS for 1 day prior to the incorporation to assess the effect of M1 activation on the surrounding 
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cells. For macrophages in microgels without LPS treatment, the cells proliferated over time in a similar 
rate to those cultured separately as shown in Figure 3.8, Figure 3.15(b). Unlike those macrophages 
which proliferated confined to the microgels, the cells in this multiplex system were able to eventually 
break and migrate out of the microgel after 7 days of culture, forming a colony at the periphery of the 
microgel, within the interstitial space between the microgel and the surrounding hydrogel. This 
suggested that the extracellular matrix (ECM) degradation and the growth potential of macrophages 
was enhanced by the presence of neighboring fibroblasts. However, the fibroblasts did not show any 
significant physiological change during the period.
Figure 3.15 (a) Macrophage-laden microgels were embedded into a larger fibroblast tissue construct to 
fabricate multiplex tissue model. (b,c) The changes in their phenotypes were monitored over time (scale 
bar: 100 μm). The macrophages were treated with LPS prior to incorporation (untreated macrophages 
were used as a control). (d) A magnified view of the macrophages within the fibroblast tissue over time 
(scale bar: 50 μm).
When the macrophages were treated with LPS prior to multiplex tissue fabrication, the proliferation 
of the macrophages and their migration out of the microgels were more markedly pronounced, likely 
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due to the M1 activation enhancing their inflammatory potential Figure 3.15(c), 3.15(d). More 
interestingly, unlike the fibroblasts shown in Figure 3.15(b), which did not show any noticeable change, 
the surrounding fibroblasts began to spread at day 3 and proliferated around the macrophages, akin to 
the hypertrophic fibroblast growth in a wound healing process.46 To the contrary, previous studies have 
shown that LPS-activated M1 macrophages suppress the fibroblast proliferation. Since the macrophages 
were only treated with LPS for 1 day prior to incorporation, and the normal culture condition was 
maintained throughout the culture, the macrophages did not undergo full M1 activation and both M1 
and M2 characteristics were retained, leading to both M1 activated macrophage proliferation and 
migration and fibroblast proliferation induced by M2 activated macrophages. This explanation was 
partly explained by the lack of macrophages showing dendritic morphology which is a hallmark of M1 
activation. Overall, these results demonstrated the effect of macrophages at different stages of activation 
on the surrounding fibroblastic cells was well demonstrated and characterized by the multiplex tissue 
model.
Figure 3.16 (a,b) Macrophage-laden microgels were embedded into a larger hepatocarcinoma tissue 
construct to fabricate multiplex tissue model. The changes in their phenotypes were monitored over 
time (scale bar: 100 μm). The macrophages were treated with LPS prior to incorporation (untreated 
macrophages were used as a control). The arrow indicates the activated macrophages migrating out of 
the microgel. There was a significant decrease in hepatocarcinoma cell density surrounding the 
macrophage (highlighted area). (c) A magnified view of the macrophages within the hepatocarcinoma 
tissue over time (scale bar: 50 μm).
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3.3.5.2 Hepatocarcinoma Tissue
Macrophages play important and complex roles on the tumor tissue with both progression and 
suppression, due to their plasticity in regard to Mϕ polarization.47-50 Macrophage cells are recruited by 
cancer cells, called tumor-associated macrophages (TAM), via paracrine effect and promote tumor 
progression by acquiring M2 phenotype and activate tumor tissue growth such as angiogenesis, 
immunosuppression and metastasis. In fact, tumor tissues generally consist of substantial portions of 
TAM. However, on the other hand, macrophages are also capable of promoting anti-cancer activities, 
such as proinflammatory cytokine expression (e.g. interleukins, TNF-a), antigen presentation and T cell 
activation, cytotoxic intermediates (e.g. nitric oxide, reactive oxygen species, by acquiring M1 
phenotype via interferon-γ and co-stimuli. This anti-cancer effects of macrophages are now actively 
explored in cancer immunotherapy.51, 52 To investigate the effect of reciprocal macrophages in microgels 
in cancer progression, macrophage-laden microgels were embedded in a hydrogel with 
hepatocarcinoma cells, and their behavior was monitored over time Figure 3.16. Similar to those 
surrounded with fibroblasts in Figure 3.15, the macrophage proliferated and eventually migrated out of 
the microgels and formed clusters at their periphery even without the LPS induction, indicating the 
surrounding hepatocarcinoma cells also similarly promoted the macrophage activation Figure 3.16(a). 
However, the surrounding hepatocarcinoma cells were not significantly affected during the culture 
period. When the macrophages were treated with LPS prior to tissue fabrication, there was a major 
difference in both macrophage and hepatocarcinoma cell activities Figure 3.16(b), (c). First, there were 
more macrophages displaying M1 phenotype (i.e. dendritic filopodia projection) generated over time 
than those surrounded by fibroblasts shown in Figure 6c. Furthermore, the dendritic M1 macrophages 
migrated out of the microgel and significantly increased in number. This result, along with that in 
fibroblast tissue model, highlighted that the LPS-induced M1 polarization was synergistically promoted 
by the presence of surrounding cancer cells, more so than normal cells,41 likely due to paracrine effects. 
More importantly, there was extensive hepatocarcinoma cell death around the activated macrophage 
cluster, demonstrating that M1 activated macrophages showed anti-cancer activity highlighted area in 
Figure 3.16(b), which has been similarly demonstrated in previously published reports.53-55 Since 
macrophages are not able to directly contact the cancer cells or activate T cells in this in vitro model, it 
was speculated that the activated M1 macrophages surrounded by cancer cells likely expressed elevated 
levels of inflammatory cytokines leading to anti-cancer effects. In sum, the results of phenotypical 
changes observed with the multiplex tissue model have successfully demonstrated the feasibility and 
effectiveness of this system as an in vitro tissue model to simultaneously study various biological 
processes for multiple cell types.
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3.4. Conclusion
In this study, microfluidics-based fabrication of cell-laden microgels as microtissue constructs is 
presented, in which monodisperse aqueous droplets of a gel precursor solution generated from a 
microfluidic device with double flow-focusing channel geometry are crosslinked to generate the 
microgels. The biocompatibility of the microgels was well maintained regardless of their size, which 
was controlled by the flow rates during droplet generation. Mechanical properties of the microgels, 
controlled by the concentration of the gel-forming polymer, significantly influenced the proliferation 
and the LPS-induced differentiation (‘Mϕ polarization’) of encapsulated macrophages. Using these 
macrophage-laden microgels as dispersible microtissues, they were incorporated into a larger tissue 
construct to create “multiplex” tissue model, in which macrophage cells were compartmentalized within 
the microgel, but allowed to communicate with the surrounding tissue via diffusion. It could be argued 
that this model is more physiologically relevant and more closely mimic the real tissue than 
conventional co-culture systems. In this model, the macrophage proliferation, differentiation and 
migration were mediated by the type of surrounding cells, as well as LPS-induced activation. 
Conversely, the surrounding cells were also influenced by the state of macrophages. Taken together, the 
in vitro multiplex tissue model presented in this work could be applied to various types of tissues for 
analyzing complex and interdependent biological processes. In addition, the microgel-based tissue 
constructs may be used as an injectable form of implantable tissues for future clinical applications.
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PART IV
Combined effects of co-culture and substrate mechanics on
3D tumor spheroid formation within microgels prepared
via flow-focusing microfluidic fabrication
4.1. Introduction
Tumor spheroids have been extensively investigated as a three-dimensional (3D) tissue model to study 
various aspects of cancer physiology as well as for high throughput screening applications, as they can 
mimic 3D solid tumor tissues more closely than conventional two-dimensional monolayers.1-3 In 
addition, there are several methods available to efficiently develop spheroids in large quantities, both 
templated (e.g. microwells) and suspension (e.g. hanging drop) cultures.4-6 This is possible due to the 
high proliferative nature and strong cell-cell interactions of various tumor cells, which are hallmarks of 
tumor progression, such that even under conventional in vitro cell culture conditions, the cells easily 
grow in numbers and often naturally aggregate to form spheroid structures. More recently, scaffold 
materials have been increasingly adopted to provide 3D tumor microenvironment resembling natural 
extracellular matrix (ECM), such as microgels (e.g. alginate and gelatin microbeads), to induce more 
complex cell-matrix as well as cell-cell interactions during spheroid formation.7-10 Due to the 
advancement in microfabrication technology, the size and shape of these scaffolds can be fine-tuned to 
generate tumor spheroids with more complex and elaborate morphology. In addition, as the physical 
properties of tumor microenvironment have also been shown to influence the tumor formation and 
physiology, the mechanical properties of the scaffold are controlled to influence tumor spheroid 
formation.11, 12 The use of scaffold also has the advantage of incorporating different types of cells in 
predefined numbers to generate heterogeneous spheroids.13, 14 Furthermore, the topological features of 
the hydrogel surface have also been shown to influence the behavior of tumor cells.15, 16 Flow-focusing 
microfluidics has recently gained significant interest in the field of biomaterials, as it can generate liquid 
droplets with controlled, monodisperse size and architecture in high yield and biocompatibility.17-19
These droplets are used to encapsulate a wide array of biologically relevant molecules (e.g. therapeutic 
molecules, proteins) and species (e.g. bacterial and mammalian cells) for delivery applications. 
Moreover, the droplets consisting of gel-forming polymers can be crosslinked to develop microgels as 
cell culture platforms for tissue engineering applications.20-25 In this study, a microfluidic device with 
double flow-focusing channel geometry was used to fabricate microgels encapsulated with tumor cells, 
in order to create uniform-sized, microgel-based 3D tumor spheroids. The aqueous droplets of 
methacrylic gelatin, a gel-forming polymer, dispersed with breast adenocarcinoma cells (i.e., MCF-7) 
were first generated by the microfluidic device, followed by photo-crosslinking to develop microgels 
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containing tumor cells. Gelatin-based hydrogels have long been widely used as 3D cell culture 
platforms for tissue engineering applications. For example, gelatin, which is derived from collagen, 
retains cell recognition domains such as cell adhesion ligands (e.g., Arg-Gly-ASP (RGD) peptide) and 
matrix metalloproteinase (MMP) domains that are crucial for cellular activities such as proliferation 
and migration.21, 25-29 Due to the biocompatible and bioactive environment imparted by the crosslinked 
gelatin network, the cells would proliferate and eventually turn into spheroids within the microgels. 
There have been numerous studies on developing tumor spheroids using various cell sources, including 
the oft-used MCF-7 cells.30-33 However, most of these studies were performed either in suspension 
culture or on 2D substrate, and tumor spheroid formation under 3D environment are not extensively 
investigated to date. This study not only allows the investigation of tumor spheroid formation within 
size-controlled microgels, but also the effect of mechanical environment of tumor spheroid formation 
could be further explored by controlling the mechanical properties of the microgels with the polymer 
concentration. Furthermore, the tumor cells were co-cultured with a different type of cells, either 
fibroblasts or macrophages which have been well known to be involved in tumor progression, to further 
influence the spheroid formation within the microgels. The results of this study would delineate the 
combined effects of co-culture and ECM mechanics on the tumor spheroid formation.
4.2. Materials and methods
4.2.1. Fabrication of a Microfluidic Device
The silicon master for the PDMS-based microfluidic device was fabricated on a silicon wafer using a 
standard photolithography. Briefly, SU-8 100 (MicroChem Corp.) as a photoresist was first spin-coated 
on a silicon wafer at 1750 rpm for 30 seconds, and then baked at 65 °C for 20 minutes, followed by 
95 °C for 50 minutes to harden the photoresist. The height of the photoresist became approximately 150 
μm. The photomask with a pattern for the microfluidic channel was placed on top of the wafer, and 
irradiated with UV to fabricate the patterned area. After baking at 95 °C to further strengthen the 
patterned area, the wafer was placed in SU-8 developer to remove the non-fabricated area. The wafer 
was washed with isopropanol and dried. The channel schematic is shown in Figure 4.2. PDMS 
elastomer was fabricated on top of the silicon master (base:curing agent = 10:1, Sylgard®184 Silicone 
Elastomer Kit, Midland, MI, USA). The PDMS mixture was first degassed under vacuum, and cured 
for 3 hours at 80 °C. The PDMS elastomer with the channel pattern engraved on the surface was 
detached from the master, and fluid inlets and outlets were created using a hole puncher (0.5 mm 
diameter). Finally, a glass slide and the PDMS were treated with oxygen plasma (Harrick Plasma) for 
30 seconds and permanently bonded to each other to fabricate the PDMS microfluidic device. To inject 
fluids into and collect the fluid from the microfluidic device, plastic tubings (Tygon®, Saint-Gobain 
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Performance Plastics, Merrimack, NH, USA) were connected to the inlets and outlet of the microfluidic 
device.
4.2.2. Immunocytochemistry
Immunocytochemical labeling of cells encapsulated in microgels was performed to visualize the 
characteristic biomarkers. Briefly, a cell-laden microgel sample was first fixed in 4 % formaldehyde
solution overnight at 4 °C. After washing with PBS, the sample was incubated in a PBS-DS (5 % donkey 
serum in PBS) as a blocking solution for 30 minutes. After removing the blocking solution, the sample 
was incubated with primary antibodies for 2 hours at room temperature. After removing the antibody 
solution and washing with PBS, the sample was postfixed with 4 % formaldehyde for 5 minutes. After 
washing with PBS, the sample was treated with 0.3% Triton X-100/PBS-DS (PBST-DS) for 30 min. 
After washing with PBS-DS, the sample was incubated with fluorophore-conjugated secondary 
antibodies and 4′,6-diamidino-2-phenylindole (DAPI, 100 ng mL−1) for 2 hours at room temperature. 
After removing the antibody solution and washing with PBST 3 times, the fluorescent image of the 
hydrogel surface was captured with a confocal microscope (FV1000, Olympus, Shinjuku, Tokyo, Japan).
4.2.3. Determination of droplet concentrations
The overall MGel concentration of the droplet after the merging of core and shell regions was 
estimated by the volumes of core and shell regions determined from the microscopic observation. 
Briefly, there was a clear border between core and shell regions, which are Aq1 and Aq2 phases, 
respectively, immediately after droplet formation. The volumes of the core (Vc) and the shell (Vs) was 
calculated, and their relative portions were used to calculate the overall concentration (CT), 
  VT was the total droplet volume, Cc and Cs were the concentrations of core and shell, respectively, 
and rc was the radius of the core. In this study, the average Vc/V and Vs/V were 0.6 and 0.4. The CT are 
calculated as follows: 
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Table. 4.1 The concentrations of core (Cc) and shell (Cs) regions of droplets, and the final concentration 
of droplets after merging (CT). 
4.2.4. Synthesis of methacrylic gelatin (MGel)
The methacrylate conjugation to gelatin was accomplished following a previously published method.21, 
25, 34 In a typical experimental set-up, gelatin (10 g, Sigma Aldrich, St. Louis, MO, USA), 4-
dimethylaminopyridine (1 g, Sigma Aldrich), and 4-methoxyphenol (0.1g, Sigma Aldrich) were 
dissolved in 100 mL dimethylsulfoxide at 50 °C. Then, glycidyl methacrylate (4 mL, S0.1gigma Aldrich) 
was slowly added and reacted for 2 days at 50 °C under dry N2. The product was purified by dialysis 
against deionized water for 2 days, changing the water three times a day, and dried by lyophilization. 
The chemical structure of the product was analyzed using 1H-NMR spectroscopy. (Figure 4.1)
Figure 4.1 1H-NMR spectrum of methacrylic gelatin (MGel). Characteristic peaks (a and b) of 
methacrylate are noted. 
59
4.2.5. Fabrication of cell-laden microgels
The polydimethylsulfoxane (PDMS)-based microfluidic device having a “double” flow-focusing 
channel was fabricated using a standard photolithography and PDMS (Sylgard®184 Silicone Elastomer, 
Dow Corning) molding technique (detailed processing steps and channel geometry are included in 
Figure 4.2). 21, 25 The channel consisted of two inlets for aqueous phases containing (Aq1 and Aq2) and 
one inlet for oil phase (O). Aq1 would become the core of a droplet, while Aq2 would become the shell 
(Figure 4.3(a), Figure 4.2). Aq1 and Aq2 consisted of MGel and 0.2 % (w/v) Irgacure 2959® as a photo-
initiator in phosphate buffered saline (PBS, pH 7.4). The concentrations of MGel in Aq1 and Aq2 
explored in this study were 5 and 8, 7 and 10, 9 and 12, 11 and 14, and 13 and 16 % (w/v), respectively. 
O consisted of 20 % Span®80 (Sigma Aldrich) as a surfactant in mineral oil. In Aq1, human breast 
adenocarcinoma cells, MCF-7 (ATCC®), were dispersed in the Aq1 at 1 × 107 cells mL-1. For co-culture 
conditions, either fibroblasts (3T3, ATCC®) or macrophages (RAW264.7, ATCC®) were mixed with 
MCF-7 cells in varying ratios. The fluids were injected into the microfluidic device using electronic 
pumps (Legato®100, KD Scientific). The flow rate of Aq1 and Aq2 was 125 μL hr-1, while keeping the 
flow rate of O at 500 μL hr-1, resulting in droplets with 100 μm average diameter. The droplets were 
then irradiated with UV for 2 minutes (intensity: 200 mW, distance: 5 cm, emission filter: 250-450 nm, 
Model S1500, Omnicure®) to fabricate the cell-laden microgels. The microgels were washed 
extensively with PBS to remove residual oil, and incubated in the cell culture medium (RPMI 1640 
supplemented with 10 % fetal bovine serum and 1 % penicillin/streptomycin, all purchased from 
Thermo Fisher) at 37 °C under 5 % atmospheric CO2. Due to the difficulty of directly measuring the 
mechanical properties of microgels, larger MGel hydrogel disks (8 mm diameter, 1 mm thickness) at 
the same MGel concentrations were fabricated by placing the precursor solution in a custom-made mold 
and applying the same photo-crosslinking step used to develop the microgels, as stated above, and their 
elastic moduli were obtained from uniaxial compression experiments.35, 36 Each hydrogel disk was 
compressed at a rate of 1 mm min-1 using a universal testing machine (Model 3343, Instron). The elastic 
modulus was calculated from the slope of a stress-strain curve at the elastic region (first 10 % strain).
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Figure 4.2 Schematic illustration of double flow-focusing channel geometry of the microfluidic device 
used to generate cell-laden microgels.
4.2.6. In vitro evaluation
4.2.6.1. Viability and proliferation
The viability of the cells encapsulated in the microgels were evaluated using LIVE/DEAD Cell 
Viability Assay kit (Thermo Fisher), following the manufacturer’s instuctions. Briefly, the cell-laden 
microgels were treated with calcein-AM and ethidium homodimer-1 to fluorescently label live (green) 
and dead (red) cells. The cells were visualized with a fluorescent microscope (XDS-3FL, Optika) and 
counted. The viability was reported as the percentage of live cells from the total number of cells. The 
viability was measured at various time points. The proliferation rate (kP) of encapsulated cells was 
determined by counting the number of live cells at various time points, and the plot of the normalized 







Nt was the number of viable cells at time, t, and N0 was the initial number of viable cells at t=0.
21, 37
4.2.6.2. Immunostaining
To visualize the biomarker expression of cells encapsulated in microgels at different stages of growth, 
immunofluorescent labeling of CD80 for macrophage and E-cadherin (E-cad) for MCF-7 cells was 
performed (detailed immunocytochemistry protocol is described in 2.2 section).38-41 Hamster anti-
mouse CD80 and rat anti-mouse E-cad were used as primary antibodies (1:250 dilution). 
AlexaFluor®568-linked anti-hamster IgG and AlexaFluor®488-linked goat anti-rat IgG were used as 
secondary antibodies (1:250 dilution). The cell nuclei were stained with 4',6-diamidino-2-phenylindole 
(DAPI, Sigma Aldrich). The labeled cells within the microgels were imaged using a confocal 
fluorescence microscope (FV1000, Olympus).
4.3. Results and Discussion
4.3.1. Microfluidic fabrication of cell-laden microgels
The bioactive microgels encapsulated with spheroid-forming breast tumor cells (i.e. MCF-7) were 
fabricated by a microfluidic device with flow-focusing channel (Figure 4.3). The flow-focusing 
geometry of the microfluidic channel allows the formation of monodisperse aqueous droplets via shear 
stress applied by the oil flow. To fabricate cell-laden microgels, the aqueous droplets consisted of gel-
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forming macromer, methacrylic gelatin (MGel), and photoinitiator in order to apply photocrosslinking 
scheme. Herein, the “double” flow-focusing microfluidic channel geometry was utilized, in which one 
aqueous phase (Aq1) is allowed to enter the second aqueous phase (Aq2) before being pinched off to 
form droplets. Our previous studies have demonstrated that this particular channel geometry could 
significantly enhance the viability of the encapsulated cells by directing the cells to the center of the 
droplets, and eventually the microgels, by including the cells only in Aq1. This strategy minimized the 
cells from contacting the oil phase containing surfactants, which is well known to cause cytotoxic 
effects.39, 42 
Figure 4.3 (a) Schematic illustration of the fabrication of cell-laden microgels using a “double” flow-
focusing microfluidic device. Droplets of gel precursor solution dispersed with tumor cells are 
photocrosslinked to generate the microgels. The cell-laden microgels are continuously cultured to allow 
the cells to proliferate and form spheroids. (b) A microscopic view of the microfluidic device (scale bar: 
200 μm). (c) Representative optical (left) and fluorescent (right) images of cell-laden microgels (scale 
bar: 50 μm). The cells were fluorescently labeled to visualize live (green) and dead (red) cells.
To help keep the cells within the core region of the droplets before employing photo-crosslinking, the 
MGel concentration in Aq2, which would become the shell region, was higher than that of Aq1, again 
following our previous studies.21, 25 With the higher viscosity of shell region, the cells within the core 
region would more likely remain there than move outwards, further minimizing the chances of cells 
contacting the surrounding oil phase. The microscopic observation of resulting microgels indeed 
revealed that the cells generally remained within the core region, even after the core and shell regions 
eventually merged via diffusion and photo-crosslinked to form microgel (Figure 4.3c). One of the 
advantages of flow-focusing microfluidics in creating droplets is the precise control of size by simply 
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adjusting the flow rates of aqueous and oil phases. Also, the droplets are monodisperse in size under the 
given flow rates, as shown in Figure 4.3b, especially compared with those created by non-specific high 
shear (e.g. sonication) which results in wider size distributions.43 Here, the ratio of aqueous to oil flows 
was kept at 0.2, which resulted in droplets with the average diameter of 100 μm.
Figure 4.4 (a) Elastic moduli (E) of MGel hydrogels at varying concentrations. (b) The viability of 
MCF-7 cells encapsulated in microgels at varying MGel concentrations, measured at various times up 
to 7 days.
4.3.2. Effect of microgel mechanics on tumor spheroid formation
To investigate the effect of microgel mechanics on the viability and proliferation of the encapsulated 
cells, the mechanical properties of the microgels were controlled by varying the MGel concentrations. 
Five different sets of MGel concentrations for Aq1 and Aq2 were explored; 5 % and 8 % (C1), 7 % and 
10 % (C2), 9 % and 12 % (C3), 11 % and 14 % (C4), and 13 % and 16% (C5). The overall MGel 
concentration after the merging of core and shell regions were estimated to be 6.2 % (C1), 8.2 % (C2), 
10.2 % (C3), 12.2 % (C4) and 14.2 % (C5), determined based on the relative amounts of core and shell 
regions (detailed calculations are provided in Supporting Information). Due to the difficulty of directly 
measuring the mechanical properties of microgels, larger hydrogels at the same MGel concentrations 
via photo-crosslinking were separately fabricated, and their elastic moduli were obtained from uniaxial 
compression (Figure 4.4a). The moduli could be controlled in a wide range, from 0.7 kPa to 30 kPa, by 
varying the MGel concentration.
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Figure 4.5 Microscopic images of cell-laden microgels at various mechanical stiffness (from C1 to C5), 
controlled by MGel concentration, cultured over time (scale: 50 μm).
The MCF-7 cells encapsulated in the microgels with varying mechanical stiffness were cultured, and 
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their viability and proliferation were measured. The cell viability was well maintained regardless of the 
microgel conditions, all above 80 %, demonstrating the biocompatibility of the microfluidic process 
and the 3D microenvironment provided by the microgels (Figure 4.3 and Figure 4.4). However, there 
was a significant difference in cell proliferation in response to varying mechanical stiffness of the 
microgels. The cell proliferation increased substantially with increasing mechanical stiffness, as 
identified by the microscopic observation (Figure 4.5). To further quantify the rate of proliferation at 
different microgels, the number of cells were counted at various times throughout the cell culture, and 
the plot of number of cells vs. time was fitted with a population doubling power-law model to obtain 
the proliferation rate (k) (Figure 4.6). In accordance with the microscopic images, the k values increased 
with mechanical stiffness of the microgels. Previous studies have similarly demonstrated that the 
proliferation of MCF-7 cells was enhanced on stiffer substrates.44 However, the majority of the studies 
have been performed on the surface (2D). Since medium diffusion into the microgel and the available 
inner space in the microgel for cell growth becomes more limited at higher stiffness, which would be 
viewed as deterrent for cellular growth, the increase in proliferation under those circumstances revealed 
that the mechanotransduction imparted by the higher stiffness of the microgel had significant influence 
over proliferation. Moreover, the overall microgel dimension did not change during the proliferation, 
suggesting that the cells could remodel the internal structure to accommodate the increasing number of 
cells. 
Figure 4.6 (a) The number of live MCF-7 cells at various times (Nt) normalized with the initial number 
of live cells (N0) plotted over time. (b) The proliferation rate (k) obtained by fitting the plot in (a) with 
Eq.(1). (*p<0.05, n = 10)
 With the continued cell culture up to 2 weeks, the cells formed a collection of smaller spheroids within 
the microgels, in which the cell clusters organized into more well defined spherical entities (Figure 4.7). 
The size of these spheroids was larger at higher microgel stiffness, suggesting that greater number of 
cells during the proliferation naturally led to the formation of larger spheroids. Especially at C4 and C5, 
the cells outgrew the size of the microgels, such that some of the cells could migrate out of the microgels. 
Overall, these results highlighted that the MCF-7 cells within the microgels showed higher proliferation 
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at greater microgel stiffness, and the cells eventually turned into spheroids. However, it should be noted 
that the continued cell proliferation did not lead to a singular large spheroid in a microgel, rather a 
number of smaller spheroids co-existing within the microgel.
Figure 4.7 The tumor spheroid formation within microgels with varying mechanics after 14 days of 
cell culture (scale: 50 μm). A collection of smaller spheroids was developed within the microgel.
4.3.3. Effect of co-culture on tumor spheroid formation
It has been widely reported that the many tumor tissues contain a heterogeneous mixture of different 
cell types which help promote tumor growth and metastasis (Figure 4.8a).45-47 For example, tumor-
associated macrophages are found in most solid tumors, and involved with angiogenesis, immune 
suppression and tissue remodeling which help tumor progression.45, 46 Fibroblasts are also similarly 
recruited by tumor cells and become activated as tumor-associated fibroblasts which similarly aid in 
tumor growth by promoting angiogenesis and tissue remodeling.47, 48 Therefore, it was hypothesized 
that the presence of these supporting cells would help turn the MCF-7 cells into a larger and more 
mature (compact) tumor spheroid within a microgel. To investigate the role of supporting cells on the 
tumor spheroid formation within microgels, either macrophages or fibroblasts are co-cultured with 
MCF-7 cells within the microgels, and tumor spheroid formation was monitored.
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Figure 4.8 (a) Schematic illustration of tumor microenvironment, consisting of multiple types of cells. 
Reprinted with permission.39 Copyright 2016 Springer Nature. (b) Optical (left) and fluorescent (right) 
microscopic images of microgels encapsulated with varying amounts of macrophages co-cultured with 
MCF-7 cells (scale bar: 50 um). The cells were fluorescently labeled to visualize live (green) and dead 
(red) cells.
First, the MCF-7 cells were co-cultured with macrophages (RAW264.7 cell line) in microgels at 
different macrophage contents (30 %, 50 % and 70 % macrophages) (Figure 4.8b). The MGel 
concentration of the microgel was fixed at C3. Regardless of the cell compositions, the viability of the 
cells was high and well maintained throughout the culture. In addition, the cells all underwent 
significant proliferation over the course of cell culture. At lower macrophage content (30 %), the cell 
proliferation and spheroid morphology was similar to those with only MCF-7 cell, in which several 
smaller tumor spheroids were formed within a microgel. When the amount of macrophages was 
increased (50 % and 70 %), the cells proliferated at faster pace and transformed into a large, single 
tumor spheroid with greater uniformity within a microgel. Remarkably, at the highest macrophage 
content (70 %), the tumor spheroids were more readily formed, only by day 3 of culture, further 
highlighting the role of macrophages in promoting tumor spheroid formation. In all conditions, there 
were filopodial projections the periphery of tumor spheroids, a hallmark of tumor invasion and 
metastatic potential.49-51 This observation further gave evidence that the macrophages were actively 
involved with the tumor progression and spheroid formation. Next, MCF-7 cells were co-cultured with 
fibroblasts in the microgels at different ratios and the tumor spheroid formation was examined (Figure 
4.9). At lower fibroblast content (30 %), the cell proliferation was not significantly different from that 
with only MCF-7 cells. In addition, the spheroids formed within a microgel were smaller than those co-
cultured with macrophages. At higher fibroblast content (50 %), more well-defined and larger tumor 
spheroids were formed. However, the tumor spheroids were markedly smaller, and the proliferation was 
slower than those co-cultured with macrophages. Moreover, at the highest fibroblast content (70 %), 
the cell proliferation and tumor spheroid formation was reduced compared with those with lower 
fibroblast content. This result suggested that the effect of fibroblast on promoting tumor spheroid 
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formation may not have been as potent as the macrophages, and the initial reduced number of MCF-7 
cells in the microgels with higher fibroblast content likely led to slower tumor progression. Taken 
together, the tumor spheroid formation was greatly aided by the presence of supporting cells, and this 
enhancement effect was varied depending on the cell type.
Figure 4.9 Optical (right) and fluorescent (left) microscopic images of microgels encapsulated with 
varying amounts of fibroblasts co-cultureed with MCF-7 cells (scale bar : 50 μm). The cells were 
fluorescently labeled to visualize live (green) and dead (red) cells.
4.3.4. Combined effect of co-culture and microgel mechanics on tumor spheroid formation
The results presented above clearly demonstrated that both the mechanical properties of the 
surrounding matrix and the presence of supporting cells play important roles in tumor spheroid 
formation within the microgels. Therefore, to elucidate their combined effects, the co-culture of MCF-
7 cells with supporting cells within microgels with varying mechanical properties was performed, and 
the change in tumor spheroid formation was evaluated.
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Figure 4.10 Optical (left) and fluorescent (right) microscopic images of MCF-7 cells and macrophages 
(5:5 ratio) co-encapsulated in the microgels with various mechanical stiffness (from C1 to C5) (scale 
bar: 50 um). The cells were fluorescently labeled to visualize live (green) and dead (red) cells.
The MCF-7 cells alone in microgels with varying mechanical stiffness demonstrated increase in 
proliferation with increasing mechanical stiffness, as demonstrated in Figure 4.5 and Figure 4.6. With 
the co-culture with macrophages, the trend in proliferation rate was similar, in which the cell 
proliferation increased with the mechanical stiffness of the microgels, but the cell proliferation was 
greatly enhanced at lower mechanical stiffness (C1 and C2) (Figure 4.10). In C1, the cells continue to 
proliferate and eventually broke out of the microgel, due to the structural weakness. But the cells were 
closer to aggregates that continue to spread without forming a compact, well-defined spherical form 
that defines tumor spheroids. However, beginning with C2, the larger tumor spheroid that covers the 
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entire microgel volume with the peripheral filopodial projection was shown. With increasing 
mechanical stiffness of the microgels, the tumor spheroids formed more quickly, such that larger tumor 
spheroids began to form only after day 3 of culture at C4 and C5. However, at the highest mechanical 
stiffness (C5), even though the tumor spheroid formation occurred earlier than other conditions, the size 
of spheroids were smaller, likely due to the increased mechanical strength of the microgels likely 
increased the metabolic stress and also acted as a physical barrier against forming larger spheroids.11
Regardless, at a wide range of mechanical stiffness of the microgels, the cells all proliferated and formed 
a large, compact spheroid within the microgels rather than several smaller spheroids, further 
establishing the important role of co-cultured macrophage on the tumor spheroid formation.
Immunocytochemical analysis of the characteristic biomarkers of MCF-7 cells and macrophages within 
the microgel was performed to further analyze their biochemical changes during the tumor spheroid 
formation (Figure 4.11). For MCF-7 cells, the expression of E-cadherin (E-cad), a calcium-dependent 
transmembrane protein responsible for cell-cell junction and communication and known biomarker for 
epithelial cells, was targeted and analyzed, since the expression behavior of E-cad in breast mammary 
cells is well known to be altered, often down-regulated, which leads to tumor progression via epithelial-
to-mesenchymal transition.52, 53 For macrophages, CD206 (an M2 phenotype marker) and CD80 (an M1 
activation marker) were targeted to monitor the degree of macrophage activation during tumor spheroid 
formation. For tumor-associated macrophages, their M1 activation which is involved with inflammatory 
and tumor-suppressive activities is down-regulated and their anti-inflammatory and immune-
suppressive potentials are up-regulated, helping tumor progression.54 Regardless of the microgel 
stiffness, the E-cad expression per cell significantly decreased over time, which was in line with many 
previous studies demonstrating their down-regulation. This suggested that the MCF-7 cells within the 
microgels became highly tumorigenic during their proliferation and spheroid formation. In addition, the 
CD206 expression was generally much larger than that of CD80 from C1 to C3, which corroborate with 
previous reports showing tumor-associated macrophages acquire M2 phenotype to promote tumor 
progression. The concurrent decrease in CD80 expression over time and the generally diminished level 
of CD80 expression regardless of gel mechanics were also indicative of the M1 suppression, which 
coincided with the increased CD206 expression and further highlighted the tumor-promoting role of 
macrophages within tumor microenvironment. Interestingly, the relative expressions of CD206 and 
CD80 were dependent on the gel mechanics. For example, CD206 expression was much lower at higher 
gel stiffness (C4 and C5) as compared to lower stiffness (from C1 to C3). Also, the initial CD80 
expression at day 1 was higher than CD206 expression at C4 and C5, although it decreased significantly 
afterwards and CD206 expression increased over time. This indicated that at higher gel stiffness, the 
macrophage favored M1 phenotype, but the presence of tumor cells influenced the Mφ polarization 
more towards tumor-promoting M2 phenotype. In addition, while the CD206 expression showed 
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increase over time at C4, it remained substantially low throughout the period at C5, possibly due to the 
limited permeability of microgels at higher stiffness suppressing Mφ polarization itself. These results 
highlight the gel mechanics as well as the presence of tumor cells combine to influence the macrophage 
activities. Taken together, these results evidently established the synergistic role of co-culture with 
macrophages and tunable mechanical properties of microgels on improving the tumor spheroid 
formation in microgels.
Figure 4.11 Immunocytochemical analysis of MCF-7 cells and macrophages encapsulated in microgels 
with varying mechanical properties (from C1 to C5). At various times up to 7 days, E-cadherin (E-cad), 
CD206 and CD80 were fluorescently labeled (scale bar: 50 μm). 4,6’-diamidino-2-phenylindole (DAPI) 
was used to label cell nuclei.
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4.4. Conclusion
There is a growing interest in utilizing tumor spheroids as 3D sturctures as high-thoughput screening 
platforms for cancer therapeutic development, because tissue0based platforms provide more in-depth 
biological information than conventional target molecule-based platforms. In this study, tumor 
spheroids were developed within size-controlled microgels with tunable mechanical properties as a 3D 
cell culture platform via a flow-focusing microfluidic fabrication. The double flow-focusing channel 
geometry allowed biocompatible encapsulation of cells inside aqueous droplets of gel-forming 
precursor solution, which were then photo-crosslinked to form cell-laden microgels. With breast 
adenocarcinoma cells (MCF-7), the cells encapsulated inside the microgels showed high viability 
throughout the cell culture regardless of the mechanical properties of microgel. However, the rate of 
proliferation was highly dependent on their mechanical properties; the cells proliferated faster within 
microgels with higher mechanical stiffness. MCF-7 cells alone did not lead to a mature spheroid within 
a microgel, in which all the cells form a large, compact, and well-defined spherical cell cluster, but 
rather a collection of smaller cell aggregates were formed regardless of the microgel stiffness. However, 
when MCF-7 cells were co-cultured with supporting cells, macrophages or fibroblasts, well known to 
be involved with tumor progression, the cells within a microgel proliferated and turned into a mature 
spheroid regardless of the microgel stiffness, though their rate and extent of spheroid formation was 
dependent on the microgel stiffness. Taken together, the microfluidic fabrication of cell-laden microgels 
with varying mechanical properties coupled with providing supporting cells to control tumor spheroid 
formation is expected to be an efficient strategy of generating a wide array of heterogeneous 3D tumor
spheroids as platform for drug screening applications as well as fundamental biological investigation.
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PART V
Cell subtype-dependent generation of breast tumor
spheroids within 3D mechanically tunable microgels
and their variable responses to chemotherapeutics 
5.1. Introduction
Due to the limitations of conventional two-dimensional (2D) monolayer cell culture in recapitulating 
native tissues, there is a growing need for developing 3D cell culture models that allow for more 
complex and physiologically-relevant biological analyses. In order to create 3D tissue constructs, 
biocompatible and cell adhesive materials such as hydrogels and nanofibers are often used as scaffolds 
to culture various cells.1-4 With recent advances in microfabrication technology, more precise 
manipulation of physical dimensions and complex architecture of the engineered tissues is possible.5-7
However, it is still a significant challenge for scaffold-based tissues to closely mimic complex cell-cell 
and cell-ECM interactions and maintain their long-term viability with limited diffusivity. In addition, 
the technology for mass production of 3D tissue constructs for high-throughput screening applications 
are still in its infancy. For the cells that naturally form aggregates upon proliferation preferentially over 
substrate adhesion, such as embryonic stem cells and tumor cells, they are easily guided to form 
multicellular spheroids with a defined size, which are deemed more efficient, scalable, and readily-
applicable 3D tissue constructs.2, 8-12 Spheroids consisting of non-adherent cells can be easily developed 
in a liquid suspension culture (e.g. spinner flask), but it is not feasible to precisely control their size, 
uniformity and compositions. More uniform-sized spheroids with greater are generally developed by 
culturing cells within a confined space, such as hanging drop and microwell arrays.13-15 More recently, 
microfabrication technology, such as 3D printing and microfluidics, is being adopted to generate 
spheroids with more uniformity and controlled cellular compositions.16-18 Spheroids have a number of 
features that allow for closer resemblance to native 3D tissues, making them highly attractive models 
for biomedical investigation.2, 8-12 First, spheroids consist of cells held together by extensive tight cell-
cell junctions mimicking native tissue structures. Thus, biological phenomena could be analyzed in the 
context of complex tissue physiology. Second, the cells reside in varying levels of mass transportation 
along the depth of spheroids due to diffusional limitations, making it possible to analyze of the effect 
of soluble factors on tissues in spatiotemporal detail. Third, heterogeneous spheroids consisting of 
multiple cell types can be efficiently developed via co-culture for investigation of heterogeneous 
biological networks. Despite numerous studies on the development and applications of spheroids as 3D 
tissue models, there are a few deficiencies that need to be addressed before fully embraced with clinical 
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relevance. Most notably, the effect of microenvironmental factors on spheroids has not been extensively 
studied to date. Most spheroids are generated only with highly proliferative cells, devoid of ECM. Even 
though cells can express and deposit ECM to the surrounding, leading to cell-ECM interaction during 
spheroid generation, the role of ECM especially on the initial stages of cell behavior leading to spheroid 
formation is not well understood. In addition, it is challenging to maintain spheroids in a defined size 
for a long period of time. Spheroid generation mostly relies on the growth potential of a particular cell 
type, therefore they may continue to grow in size rather rapidly with the continued cell growth, making 
it difficult to develop smaller spheroids. This would critically complicate their analysis, as the 
concentric distribution of cells along the depth could vary with changing size. In this present study, a 
microfluidic flow-focusing device was adopted to create uniform-sized spherical micro-scale hydrogels 
(‘microgels’) encapsulated with spheroid-forming tumor cells, in order to investigate the effect of 3D 
microenvironment on the cellular behavior, leading to spheroid formation. 17,19-21 Owing to the ability 
of the microfluidic device to precisely control the size of microgels that act as a vessel confining the 
spheroids, the overall size of spheroids generated within the microgel could be controlled. Moreover, 
the mechanical properties of the microgels were controlled in a wide range to elucidate the role of 
biomechanical cues imparted by the microgels.19, 20 Three different breast tumor cells, which are 
commonly categorized into three different subtypes based on malignancy, were used. 22, 23 The cell 
behavior and subsequent spheroid formation within the microgels showed highly characteristic 
dependence on microgel mechanics for each cell subtype, especially involving the formation of 
polyploidy.24, 25 Finally, to further highlight the importance of microenvironmental consideration on 
spheroids, the variable efficacy of chemotherapeutic agents was evaluated against the tumor spheroids 
in the mechanically-tuned microgels.
5.2. Material and methods
5.2.1. Synthesis of methacrylic gelatin (MGel)
Gelatin (5 g, from porcine skin, Sigma Aldrich), 4-methoxyphenol(0.05g, Sigma Aldrich) and 4-
dimethylaminopyridine (0.5 g, Sigma Aldrich) were dissolved in 50 mL dimethylsulfoxide at 50 °C. 
Glycidyl methacrylate (2 mL, Sigma Aldrich) was added dropwise and reacted for 48 hours at 50 °C 
under dry N2.26-28 The product was purified by dialysis against deionized (DI) water and dried by 
lyophilization. The methacrylation of gelatin was confirmed with 1H-NMR spectroscopy (Figure 5.1)
79
Figure 5.1. A representative 1H-NMR spectrum of methacrylic gelatin (MGel). Characteristic 
peaks corresponding to methacrylate are noted (a-c).
5.2.2. Microfluidic fabrication of cell-laden microgels
The flow-focusing microfluidic device was used to generate cell-laden droplets, which were 
photocrosslinked in situ to develop cell-laden microgels. The detailed device fabrication procedure is 
provided in detail elsewhere.19, 20, 29 Aqueous solution phases 1 and 2 (Aq1 and Aq2) both consisted of 
MGel and 0.2 % (w/v) Irgacure 2959® in phosphate buffered saline (PBS, pH 7.4). The channel 
geometry allowed Aq1 to enter Aq2 prior to droplet generation, with Aq1 becoming the core of a droplet 
(Figure 5.2a). Oil phase (O) consisted of 20 % Span®80 (Sigma Aldrich) as a surfactant in mineral oil 
(Sigma Aldrich). In Aq1, breast tumor cells, MDA-MB-231, MCF-7, or SK-BR-3 (Korean Cell Line 
Bank, http://cellbank.snu.ac.kr), at 1 × 107 cells mL-1 were dispersed. The fluids were injected into the 
microfluidic device using electronic pumps (Legato®100, KD Scientific). Varying the ratio of flow 
rates of Aq and O resulted in the change in size of droplets (Aq1 and Aq2 were kept at the same flow 
rate). Here, the flow rates of Aq and O were 100 and 500 μL hr-1, respectively, resulting in 100 μm 
average diameter. The droplets generated from the microfluidic device was immediately irradiated with 
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UV for 2 minutes (intensity: 200 mW, distance: 5 cm, emission filter: 250-450 nm, Model S1500, 
Omnicure®) to photocrosslink the droplets to develop cell-laden microgels. The microgels were washed 
extensively with PBS to remove residual oil, and incubated in the cell culture medium at 37 °C under 
5 % atmospheric CO2. The cell behavior and subsequent spheroid formation within microgels was 
monitored visually with inverted optical microscope at various times (XDS-3FL, Optika). The cell 
culture medium was RPMI1640 supplemented with 10 % heat inactivated fetal bovine serum (FBS), 2 
mM L-glutamine, 25 mM HEPES and 25 mM NaHCO3 (all purchased from Thermo Fisher) for all cell 
types.
5.2.3. In vitro evaluation of spheroids in microgels
5.2.3.1. Viability and proliferation
The viability of the cells encapsulated in the microgels were measured using LIVE/DEAD Cell 
Viability Assay kit (Thermo Fisher), following the manufacturer’s instructions. Briefly, the cell-laden 
microgels were treated with calcein-AM and ethidium homodimer-1 to fluorescently label live (green) 
and dead (red) cells, and were visualized with fluorescence microscopy (XDS-3FL, Optika). The 
viability was reported as the percentage of live cells from the total number of cells.
The proliferation rate (kP) of encapsulated cells was determined by counting the number of live cells 
at various time points up to 7 days, and the plot of the normalized number of viable cells (Nt/N0) vs. 






Nt was the number of viable cells at time, t, and N0 was the initial number of viable cells at t=0. 19, 20, 27
5.2.3.2. Fluorescent actin and nuclei visualization
To visualize the actin structure and nuclei of MDA-MB-231 cells during spheroid formation, the cells 
were labeled with fluorescein-labeled phalloidin (FITC-phalloidin, Thermo Fisher) and 4',6-diamidino-
2-phenylindole (DAPI, Sigma Aldrich), respectively.28, 30 Briefly, the cell-laden microgel sample taken 
at each time was first fixed in 4 % formaldehyde and washed with PBS. After treating with 
permeabilizing solution (0.5 % TritonTM X-100) for 5 minutes, followed by blocking solution (1 % 
bovine serum albumin and 0.1 % sodium azide) for 30 minutes, the sample was treated with FITC-
phalloidin working solution (5 U mL-1) for 30 minutes. After washing with PBS, the sample was then 
treated with DAPI (300 nM) for 5 minutes. The labeled sample was visualized using a confocal 
fluorescence microscope (FV1000, Olympus).
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5.2.4. Chemotherapeutic screening 
After 15 days of culture to develop large spheroids within microgels, they were treated with varying 
concentrations of chemotherapeutic agents, cisplatin and paclitaxel (Sigma Aldrich), up to 3 days. The 
viability of spheroids was measured using LIVE/DEAD Cell Viability Assay kit (Thermo Fisher), as 
stated above.
5.3. Results and Discussion
5.3.1. Fabrication of breast tumor cell-laden microgels
Figure 5.2. (a) A flow-focusing microfluidic fabrication of breast tumor cell-laden microgels. (b) Elastic 
moduli (E) of MGel hydrogels at various concentrations. (scale bar: 200 μm)
 A flow-focusing microfluidic device was used to generate uniform-sized aqueous droplets dispersed 
with breast tumor cells. This particular microfluidic channel geometry allowed the formation of “core-
shell” type droplets, in which one aqueous phase (Aq1) entered the other aqueous phase (Aq2) prior to 
droplet generation by the shear stress of oil phase (O) (Figure 5.2). By including the cells in Aq1, the 
cells were directed to the core region of droplets and minimized their contact with cytotoxic O during 
droplet generation.19, 20, 29 Aq1 and Aq2 consisted of gel-forming polymer, methacrylic gelatin (MGel), 
along with a photo-initiator. Methacrylate groups were conjugated to gelatin backbone to MGel, which 
has been widely used as scaffolds for cell culture applications, as they retain cell-adhesive motifs (e.g. 
RGD peptide) as well as photocrosslinkability.31-33 The MGel concentration in Aq2 was kept slightly 
higher than that of Aq1, so the polymer diffusion occurs inward and minimize the cells in the core region 
from moving outward, further prevent the cells from contacting the surrounding O.19, 20, 29 The 
subsequent photo-crosslinking to generate cell-laden microgels indeed showed the cells mostly 
remained within the core region. Furthermore, the initial delineation between core and shell regions 
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eventually disappeared, demonstrating they became homogenously merged via diffusion. To assess the 
effect of microenvironmental mechanics on the cell behavior and spheroid formation, the rigidity of the 
microgels was controlled by varying the MGel concentration. Five different pairs of concentrations 
were explored as Aq1 and Aq2; 5 % and 8 %, 7 % and 10 %, 9 % and 12 %, 11 % and 14 %, and 13 and 
16 %, which are denoted from ‘C1’ to ‘C5’. The overall MGel concentration after the merging of core 
and shell regions were estimated to be 6.2 % (C1), 8.2 % (C2), 10.2 % (C3), 12.2 % (C4) and 14.2 % 
(C5), determined based on the relative amounts of core and shell regions.19, 20 Their elastic moduli, 
determined from uniaxial compression of bulk hydrogels fabricated separately, ranged from 1.2 to 40.3 
kPa (Figure 5.2b), while their swelling ratios showed corresponding decrease from 30 to 12.5 (Figure 
5.3).
Figure 5.3. Swelling ratios (Q) of MGel hydrogels with varying rigidity (C1-C5).
It was hypothesized that the effect of microgel mechanics on cell behavior and spheroid formation 
would vary widely based on cellular subtypes. Therefore, cells from three different breast tumor cell 
lines were explored; MDA-MB-231, SK-BR-3 and MCF-7. They are commonly categorized as “triple 
negative B”, “HER2+” and “luminal A”, respectively, in decreasing order of aggressiveness.22, 23
5.3.1.1. MDA-MB-231
MDA-MB-231 cells are classified as “triple negative B” (or “basal B”), identified by the lack of three 
characteristic markers, estrogen receptor (ER), progesterone receptor (PR) and human epithelial 
receptor 2 (HER2), and generally associated with a more aggressive form of tumor, accompanied by 
several genetic alterations.22, 23, 34 The cells encapsulated in the microgels with varying rigidity 
maintained high viability (Figure 5.4a and 5.4b). Interestingly, the cell proliferation increased 
substantially with microgel rigidity, with increased number of smaller spheroids within the microgels, 
suggesting the increased mechanotransduction signals imparted by higher microgel rigidity promoted 
the cellular proliferation (Figure 5.4c and 5.4d). This is especially striking, considering the lower 
permeability of microgels at higher rigidity, which could limit media diffusion. At the lowest rigidity of 
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C1, the number of viable cells significantly decreased over time, almost devoid of cells in the microgels 
by day 9. At C2, there was a small increase in the number of cells up to day 5, but did not show further 
growth afterwards. It is widely known that many types of cells are heavily governed by 
mechanotransduction mediated by surrounding matrices transmitting biophysical cues.35-37 In 
particular, increased mechanical properties of the matrices have been shown to enhance cell survival 
and proliferation. These results also highlighted the importance of providing sufficient mechanical 
stimuli for cell survival for sustaining cellular activities as well as promoting the proliferation of MDA-
MB-231 cells in 3D microenvironment.
Figure 5.4. (a) Optical (right) and fluorescent (left) microscopic images of MDA-MB-231 cells in 
microgels with varying rigidity (C1-C5) (scale bar: 50 μm). (b) The cell viability was quantified as the 
percentage of live cells obtained from (a). (c) The plot of normalized number of live cells (Nt/N0) vs. 
time was fitted with a power-law model to obtain the (d) proliferation rate (kP) (*p<0.05).
The cellular morphology within the microgels was assessed in detail by fluorescently labeling 
cytoplasmic actin and nuclei. At C2, several cells were shown to spread and display lamellipodial 
projections, suggesting the increase in migratory potential (Figure 5.6a and 5.5a). In addition, the cells 
merged to form larger cells with multiple nuclei at earlier times at grew in size, while still demonstrating 
lamellipodial projections. This morphological changes suggested that the cells formed polyploid giant 
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cancer cells (PGCC), a hallmark of aggressive tumor progression.24, 25 PGCC with lamellipodia were 
also shown at C3, though they were generally larger with lesser extent of lamellipodia (Figure 5.6b and 
5.5b). With increased rigidity, the cell spreading became more limited but increased proliferation led to 
larger PGCC. At C4, the lamellipodia was not shown, and the size of PGCC was much smaller (Figure 
5.6c and 5.5c). But the number of smaller PGCC increased more significantly in the same time. Due to 
the limited available space within microgels at higher rigidity, the cells likely could not spread 
effectively, and PGCC could not grow in size. But further increase in proliferative capacity of cells 
produced higher number of smaller PGCC.
Figure 5.5. Fluorescent microscopic visualization of actin (green) and nuclei (blue) of MDA-MB-231 
cells in microgels with varying rigidity over 9 days of culture; (a) C2, (b) C3, and (c) C4 (scale bar: 50 
μm).
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Figure 5.6. Fluorescent microscopic visualization of actin (green) and nuclei (blue) of MDA-MB-231 
cells in microgels with varying rigidity over 9 days of culture; (a) C2, (b) C3, and (c) C4 (scale bar: 50 
μm). (d) Microscopic images of MDA-MB-231 cells in microgels with varying rigidity (C1-C5) taken 
during a long-term culture for 21 days (scale bar: 50 μm).
As a control, the MDA-MB-231 cells were separately cultured on the surface of MGel hydrogels to 
identify the difference between 2D and 3D cultures (Figure 5.7).
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Figure 5.7. Microscopic images of MDA-MB-231 cells cultured on MGel hydrogels with varying 
rigidity (scale bar: 200 um).
Similar to those in microgels, the cell proliferation increased with hydrogel rigidity. Since there was 
no spatial restriction, the cells were highly migratory. However, PGCC were not shown and cell 
aggregation was much smaller. This result indicated that under restrictive environment with higher 
hypoxia of 3D microgels may have promoted PGCC formation and merging of cells, in line with similar 
findings that have been previously reported. 25, 38
87
Figure 5.8. Microscopic images of (a) MCF-7 and (b) SK-BR-3 cells in microgels with varying rigidity 
(C1-C5) taken at various times up to 21 days (scale bar: 50 μm).
The cell-laden microgels were further cultured up to 21 days. At higher microgel rigidity of C4 and 
C5, the smaller cell aggregates merged and formed larger and more cohesive spheroids, occupying most 
of the microgels (Figure 5.6d). This was especially noteworthy given that MDA-MB-231 cells have 
been known to be highly aggressive and lack tight cell-cell adhesion, and as a result generally do not 
lead to larger cohesive spheroid formation, unless providing external stimuli such as hypoxia. It can be 
inferred that increased rigidity, coupled with restrictive environment elevating hypoxia, may have 
facilitated the spheroid formation. At intermediate C3, the number of smaller cell aggregates increased 
substantially and covered most of the microgel, but did not merge to form larger spheroids. Similar 
growth pattern was observed at C2, though at lower rate. Interestingly, the cell spreading with 
lamellipodia could still be shown at day 13, before significant proliferation occurred afterwards. At C1, 
the cell growth continued to decline, and the cells were mostly gone by 21 days. The microgel structure 
deteriorated over time due to low crosslinking density, which likely caused the cell death. Taken together, 
these results further reinforced the importance of microenvironmental mechanics, imparted by the 
microgels, on promoting tumor spheroid formation in 3D. It should also be noted that while the number 
of cells and size of spheroids grew exponentially, the overall size of microgels did not change, which 
indicated the cells within the microgels could significantly remodel the surrounding polymeric matrices 
to accommodate increased number of cells.
5.3.1.2. MCF-7 and SK-BR-3
In addition to MDA-MB-231, two other commonly used breast tumor cells, MCF-7 and SK-BR-3, 
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were encapsulated in the microgels and their activities were evaluated in the same manner. MCF-7 is 
classified as “luminal A” having ER positivity and HER2 negativity, with variable PR expression.22, 23
Luminal A cells are less aggressive (i.e. low migration, tight cell-cell junctions) than other subtypes. 
SK-BR-3, on the other hand, is classified as “HER2” having HER2 positivity and ER negativity. HER2 
cells possess intermediate aggressiveness between luminal A and basal B. Initial stage of cell culture, 
up to 7 days, showed the proliferation of MCF-7 cells increased with microgel rigidity, as similarly 
shown for MDA-MB-231 cells (Figure 5.8a). Unlike MDA-MB-231, MCF-7 cells did not show 
prominent lamellipodia, indicating the lesser degree of migratory potential, but cell aggregation and 
PGCC formation were more prominent at all microgel rigidity. Especially at higher rigidity of C4 and 
C5, a collection of smaller spheroids was formed. Similar results were observed for SK-BR-3 cells, 
though the proliferation rate was slightly lower. The size of PGCC for both MCF-7 and SK-BR-3 was 
smaller than that of MDA-MB-231 cells (Figure 5.8b). Interestingly, further culture up to 21 days 
demonstrated significant spheroid formation within microgels at all microgel rigidity for both MCF-7 
and SK-BR-3 cells, unlike MDA-MB-231 cells which only became larger and cohesive spheroids at 
higher microgel rigidity. For MCF-7, spheroids significantly increased in size and fused with one 
another to form large, singular cohesive spheroids occupying most of the microgels, rather than creating 
new, smaller spheroids, even at low microgel rigidity of C1 and C2 (Figure 5.8a). The size of spheroids 
became larger with microgel rigidity, and they eventually outgrew the size of the microgels, migrating 
out and invading the surrounding. Similar dependence of spheroid growth on the microgel rigidity was 
observed for SK-BR-3 cells (Figure 5.8b). The size of SK-BR-3 spheroids was generally smaller than 
those of MCF-7, and singular cohesive spheroids were formed in microgels with higher rigidity. At 
lower rigidity, although the spheroids grew in size substantially, they did not lead to a singular cohesive 
spheroid in a microgel, especially at C1 in which only the collection of very small spheroids was shown.
MCF-7 and SK-BR-3 cells were also cultured on MGel hydrogel surface as a control (Figure 5.9 and 
6.10). Similar to MDA-MB-231, the proliferation rates of both MCF-7 and SK-BR-3 cells increased 
with hydrogel rigidity. SK-BR-3 cells increased in numbers without forming larger aggregates or 
spheroids, only showing “grape-like” clusters, demonstrating their lack of tight cell-cell junctions. On 
the other hand, MCF-7 cells naturally formed spheroids during proliferation, more so at higher rigidity. 
These results highlight the greater tendency of MCF-7 cells to develop spheroids than other cell types, 
and it was similarly displayed in 3D microgels as well. It is also noteworthy that even though both 
MDA-MB-231 and SK-BR-3 cells did not form spheroids in 2D culture, they did form spheroids within 
microgels with varying degrees, which highlight the critical role of 3D microenvironment. The 
mechanisms of cell behavior and spheroid generation of three cell types within microgels are 
comprehensively illustrated in Figure 5.11.
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Figure 5.9. Microscopic images of MCF-7 cells cultured on MGel hydrogels with varying rigidity 
(scale bar: 200 um).
Figure 5.10. Microscopic images of MCF-7 cells cultured on MGel hydrogels with varying rigidity 
(scale bar: 200 um).
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Figure 5.11. Schematic illustration of spheroid formation mechanisms of MDA-MB-231, MCF-7 and 
SK-BR-3 cells in microgels with varying rigidity (C1-C5).
5.3.2. Chemotherapeutic response of spheroids in microgels
Spheroids have been long considered a valuable tissue model for various biological investigations with 
implications in 3D tissue physiology; cell-cell interaction and concentric distribution.39-41 More recently 
in pharmaceutical industry, there has been a growing emphasis on developing more physiologically-
relevant and patient-specific testing platforms for drug discovery. Therefore, miniaturized tissue 
constructs are increasingly investigated as a drug screening platform, with the ultimate goal of replacing 
traditional 2D monolayer cell cultures. In this regard, spheroids are considered especially attractive for 
efficient fabrication. However, conventional spheroids are generally created by the proliferative 
capacity of the constituting cells, without considering the effect of microenvironmental factors, limiting 
more accurate and expansive representation of native tissues. Therefore, the spheroids generated within 
mechanically-tunable microgels developed in this study would provide more in-depth context of 
mechanical microenvironment in determining the influence of chemotherapeutics. To account for the 
effect of microgel mechanics on the chemotherapeutic efficacy against breast tumor spheroids, varying 
concentrations of widely used drugs, paclitaxel and cisplatin, were applied to the spheroids. The ranges 
of concentrations for paclitaxel and cisplatin were 1-100 nM and 30-500 μM, respectively, which was 
first determined by applying them to 2D monolayer cultures (Figure 5.12). 
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Figure 5.12. Cytotoxicity of varying concentrations of chemotherapeutic agents, paclitaxel and 
cisplatin, against 2D monolayer cultures of (a, d) MDA-MB-231, (b, e) MCF-7, and (c, f) SK-BR-3 
cells, measured at day 1 and 3 of exposure.
In these ranges, concentration-dependent cytotoxicity was demonstrated when treated up to 3 days, and 
interestingly was not significantly affected by the cell type. The spheroids developed using the same 
cell types after 15 days of culture, which had mostly fully grown to cover the inner space of microgels 
(due to the insufficient growth, C1 was not tested).
5.3.2.1. MDA-MB-231
 The cytotoxicity of paclitaxel or cisplatin against MDA-MB-231 cells within microgels with varying 
rigidity (C2-C5) was assessed 1 day or 3 days after treatment by measuring their cell viability. 
Figure 5.13. Fluorescent imaging of live (green) and dead (red) MDA-MB-231 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 1 day of exposure to different concentrations of (a) 
paclitaxel and (b) cisplatin (scale bar: 50 μm).
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Figure 5.14. Fluorescent imaging of live (green) and dead (red) MDA-MB-231 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 3 days of exposure to different concentrations of  
(a) paclitaxel (1nM, 10nM, 50 nM and 100 nM) and (b) cisplatin (30 μM , 100 μM, 300 μM and 500 
μM) (scale bar: 50 μm). (c-f) The cell viability of MDA-MB-231 spheroids in microgels with varying 
rigidity (C2-C5) measured after 1 or 3days of exposure to different concentrations of paclitaxel (50 nM, 
100 nM) and cisplatin (300 μM, 500 μM) (*p<0.05). Solid and dotted lines represent the viabilities of 
monolayer cultures of MDA-MB-231 cells exposed to the same concentration at day 1 and 3, 
respectively.
 For paclitaxel, the decrease in viability became noticeable above 50 nM at day 1 for all microgels 
except C2 (Figure 5.14a and 5.14c, Figure 5.13a). At 100 nM, there was greater cytotoxicity at all 
microgels, as expected (Figure 5.14a and 5.14d, Figure 5.13a). Interestingly, there was a biphasic trend 
in cell viability, in which the viabilities significantly decreased for C3 and C5, 42 % and 34 %, 
respectively, compared to that of 2D monolayer culture, whereas the viability at C4 did not decrease as 
much, similar to that of 2D monolayer culture, at 73 %. This result highlighted that the spheroids within 
microgels having different mechanical properties significantly influenced their responses to 
chemotherapeutic agents. Higher permeability of microgel at lower rigidity of C3 allowed greater influx 
of paclitaxel, whereas limited permeability at higher rigidity of C5 increased the hypoxia in the 
microgels. Both factors contributed to enhancing the chemotherapeutic effects of paclitaxel. It should 
be noted that the viability at C2 was much higher than other conditions regardless of concentrations and 
exposure duration, closer to that of 2D monolayer culture, likely due to the insufficient formation of 
spheroids. Further treatment of paclitaxel for 3 days resulted in significant reduction in cell viability at 
all microgel condition, as expected, but they were still higher than that of monolayer culture(Figure 
5.14a and 5.14d), indicating the cells in spheroids could further resist the chemotherapeutic effect. 
Several previous studies have demonstrated similar multicellular resistance mediated by tight cell-cell 
junctions.42-45
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Unlike paclitaxel, the cell viability decreased continuously with increasing microgel rigidity at day 1 
against cisplatin, more prominently at higher concentration (Figure 5.14e and 5.14f, Figure 5.13b). This 
suggested that the increased hypoxia within microgels at higher rigidity had significant synergistic 
effect on the cytotoxic effect of cisplatin, but increased diffusion at lower rigidity (C3), which had 
contributed to decrease cell viability for paclitaxel, did not show the same effect. Due to the lower 
chemotherapeutic potency of cisplatin as compared to paclitaxel, as evidenced by the requirement of 
high concentration (tens to hundreds of micromolar range), increased infusion of cisplatin to the 
microgel at C3 did not have the same contributing effect. 
5.3.2.2. MCF-7
 The cytotoxic effects of paclitaxel and cisplatin at the same concentrations were also explored with 
MCF-7 spheroids in microgels, as done with MDA-MB-231 (Figure 5.16, Figure 5.15).
Figure 5.15. Fluorescent imaging of live (green) and dead (red) MCF-7 cells of spheroids in microgels 
with varying rigidity (C2-C5) taken after 1 day of exposure to different concentrations of (a) paclitaxel 
and (b) cisplatin (scale bar: 50 μm).
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Figure 5.16. Fluorescent imaging of live (green) and dead (red) MCF-7 cells of spheroids in microgels 
with varying rigidity (C2-C5) taken after 3 days of exposure to different concentrations of (a) 
paclitaxel (1nM, 10nM, 50 nM and 100 nM) and (b) cisplatin (30 μM , 100 μM, 300 μM and 500 μM)
(scale bar: 50 μm). (c-f) The cell viability of MCF-7 spheroids in microgels with varying rigidity (C2-
C5) exposed to paclitaxel and cisplatin, calculated from (a) and (b) (*p<0.05). Solid and dotted lines 
represent the viabilities of monolayer cultures of MCF-7 cells exposed to the same concentration at day 
1 and 3, respectively.
At day 1, the cells were generally more resistant to chemotherapeutics at the same concentrations as 
compared to MDA-MB-231 regardless of microgel rigidity, all similar or higher than that of 2D 
monolayer culture (Figure 5.16c and 5.16d, Figure 5.15). In addition, for both paclitaxel and cisplatin, 
lower concentrations did not result in meaningful dependence of the cell viability on microgel rigidity. 
Since MCF-7 cells more readily became cohesive spheroids than MDA-MB-231 cells, their overall 
chemoresistance probably became more prominent.
The exposure of paclitaxel at higher concentration (100 nM) at day 3 revealed an interesting biphasic 
dependence on microgel rigidity; higher cell viabilities at highest (C5) and lowest (C2) microgel rigidity, 
and lower cell viabilities at intermediate microgel rigidity (C3 and C4) (Figure 5.16a and 5.16d). This 
trend was opposite to that of MDA-MB-231 spheroids, shown in Figure 5.14d. Moreover, the cell 
viability was the largest at the highest microgel rigidity (C5) having the lowest permeability. It can be
explained that with increasing microgel rigidity, increased hypoxia within the microgels caused further 
cytotoxicity along with paclitaxel. This was further supported by the observation that the cell death 
predominantly occurred from the periphery of spheroids, indicating greater chemotherapeutic effect to
those more immediately exposed to the drug. However, highly chemoresistant spheroids formed at the 
highest microgel rigidity, coupled with limited diffusion of drug molecules, significantly reduced the 
cytotoxic effect of paclitaxel, especially compared to MDA-MB-231 spheroids.43, 46 On the other hand,
the cell death occurred from the core of MDA-MB 231 spheroids regardless of microgel rigidity and 
type of drugs, even though the cells on the periphery were more readily contacted (Figure 5.14). This 
suggested that unlike MCF-7 cells, the MDA-MB 231 spheroids were not as cohesive and as a result, 
the drug molecules could more easily diffuse into the spheroids and cause cytotoxicity from the core 
aided by increased hypoxia. The cytotoxic effect of cisplatin on the MCF-7 spheroids was not influenced 
by the microgel rigidity even at day 3 (Figure 5.16e and 5.16f). Unlike MDA-MB-231 spheroids whose 
viability decreased with microgel rigidity in response to cisplatin, likely promoted by increased hypoxia, 
it was probably not as significant factor for more cohesive MCF-7 spheroids, supported by the majority 
of cell death occurring at the spheroid periphery.
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5.3.2.3. SK-BR-3
 SK-BR-3 cells were able to form cohesive spheroids within microgels with varying rigidity, much like 
MCF-7 cells. Their response to paclitaxel and cisplatin at day 1 was also similar to that of MCF-7 
spheroids, all demonstrating high cell viability regardless of microgel rigidity (Figure 5.18c, Figure 
5.18d and Figure 5.17). In addition, the cell death also occurred from the periphery rather than the core. 
These findings also highlight the chemoresistance of cohesive spheroids.
Figure 5.17. Fluorescent imaging of live (green) and dead (red) SK-BR-3 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 1 day of exposure to different concentrations of (a) 
paclitaxel and (b) cisplatin (scale bar: 50 μm).
Figure 5.18. Fluorescent imaging of live (green) and dead (red) SK-BR-3 cells of spheroids in 
microgels with varying rigidity (C2-C5) taken after 3 days of exposure to different concentrations of (a) 
paclitaxel (1nM, 10nM, 50 nM and 100 nM) and (b) cisplatin (30 μM , 100 μM, 300 μM and 500 μM) 
(scale bar: 50 μm). (c-f) The cell viability of SK-BR-3 spheroids in microgels with varying rigidity (C2-
C5) exposed to paclitaxel and cisplatin, calculated from (a) and (b) (*p<0.05). Solid and dotted lines 
represent the viabilities of monolayer cultures of SK-BR-3 cells exposed to the same concentration at 
day 1 and 3, respectively.
96
Interestingly, the cell viability of SK-BR-3 spheroids in response to paclitaxel at day 3 showed that 
the cytotoxicity increased significantly with increasing microgel rigidity, which became more 
prominent at higher concentration (Figure 5.18a, Figure 5.18c and Figure 5.18d). At higher microgel 
rigidity, there was greater increase in cell death around the core of spheroids, compared to those at lower 
microgel rigidity, which suggested the role of hypoxia in enhancing the chemotherapeutic effect. Since 
MCF-7 cells formed more cohesive spheroids at all microgel conditions as compared to SK-BR-3, it 
could be inferred that less cohesive SK-BR-3 spheroids became more susceptible to paclitaxel 
especially at higher microgel rigidity having greater hypoxia than MCF-7 spheroids at the same 
microgel rigidity. Similarly, given very low viability at all microgel conditions, coupled with 
predominant cell death at the periphery of microgels, the increased diffusion of cisplatin at lower 
rigidity of microgels resulted in greater cytotoxicity (Figure 5.18b, Figure 5.18e and Figure 5.18f). It
was also evident that at the same concentration, the cytotoxic effect of cisplatin was more pronounced 
against SK-BR-3 spheroids than both MCF-7 and MDA-MB-231 spheroids.
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5.4. Conclusion
In this study, uniform-sized spherical gelatin microgels encapsulated with different types of breast 
cancer cells were engineered using a flow-focusing microfluidic technology. The cells within the 
microgels spheroids proliferated and turned into spheroid structures, demonstrating the biocompatible 
and bioactive properties of microgels. Importantly, their degrees of formation showed highly complex 
dependence on the cell subtypes and mechanical properties of microgels. The cellular behavior and 
subsequent spheroid formation of three breast tumor cells, MDA-MB-231, SK-BR-3 and MCF-7, 
categorized as “triple negative B”, “HER2+” and “luminal A” in decreasing order of aggressiveness, 
respectively, showed that more cohesive and large spheroids regardless of microgel rigidity were 
generated by MCF-7 cells, while MDA-MB-231 cells only became spheroids in microgels at higher 
rigidity. SK-BR-3 cells also readily formed spheroids, though more cohesive and larger spheroids were 
shown in microgels at higher rigidity. Interestingly, more aggressive MDA-MB-231 cells formed larger 
and more migratory polyploid giant cancer cells (PGCC) as they continued to proliferate, whereas 
PGCCs of MCF-7 and SK-BR-3 cells were generally smaller but they proliferated faster and more 
readily formed spheroids. Furthermore, chemotherapeutic efficacies of paclitaxel and cisplatin 
evaluated on these spheroids also highlighted that their cytotoxic effects were heavily influenced by the 
complex interplay between cell subtype and 3D mechanical microenvironment. Taken together, the 
results of this study highlight the importance of both cellular and extracellular factors on the formation 
and pathophysiology of 3D tumor spheroids, and provide biomaterial-based design criteria for 
generating tumor spheroids and their application in drug screening.
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PART VI
Facile generation hollow fiber to mimic blood vessel
using human endothelial cells via GelMa and Alginate
combination by controlled hydrogel stiffness in 3D culture
6.1. Introduction
Tissue Engineering can provide some solutions in various fields such as biomaterials, biological 
factors, usage of cells in order to restore or replace the abnormal condition. Generally, 3D cell printing 
is regarded as versatile technique for tissue engineering because of the high freedom for assigning cells 
and a lot of biomolecules are patterned geometrically.1 In this technique, one limitation required for 
biomaterials which can instant gelation behavior. The methods usesd a lot of tool, such as 3D printer, 
nozzle and so on. However, in our study, we used two kind of needle which made modified by me, that 
is facile generated method for hollow fiber compare to 3D printing. In, Alginate case, the deficiency of 
binding sites such as RGDs for cell attachment and migration in alginate dramatically impairs activities 
for encapsulated cells.2 In this study, we can solve the problem as I mentioned before, we use alginate 
and GelMa which is biomaterial derived collagen in naturally polymer, in order to mimic blood vessel. 
Alginate maintains the shape of blood vessels by physically crosslinking with calcium, and then 
irradiates with UV, allowing GelMa to bond chemically. After using citrate (chelating method) to 
remove all of the calcium bound to the alginate, the alginate diffuses out of the vessel, forming a pore, 
and the vessel can only form the GelMa backbone. And we have observed that endothelial cells 
differentiate or proliferate best under certain conditions using hydrogels of varying concentration. Also, 
endothelial progenitor cells (EPCs) are attractive cell source for treatment of ischaemia disease for their 
potentials in neovascularization.3 Therefore, it is very important to seek an endothelial cell inspired 
material for this engineering fields.
6.2. Material and methods
6.2.1. Synthesis of methacrylic gelatin (MGel)
Gelatin (5 g, from porcine skin, Sigma Aldrich), 4-methoxyphenol(0.05g, Sigma Aldrich) and 4-
dimethylaminopyridine (0.5 g, Sigma Aldrich) were dissolved in 50 mL dimethylsulfoxide at 50 °C. 
Glycidyl methacrylate (2 mL, Sigma Aldrich) was added dropwise and reacted for 48 hours at 50 °C 
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under dry N2. The product was purified by dialysis against deionized (DI) water and dried by 
lyophilization. The methacrylation of gelatin was confirmed with 1H-NMR spectroscopy.
6.2.2. Microgel using Semi IPN and IPN structure
Sodium Alginate (Junsei) and MGel are mixed in order to final concentration Alginate 0.5%, 1% and 
MGel 4%, 6%, 8%, 10%, 15%. Move the solution into the syringe and total volume is 1mL. After then 
dropping to the well plate included Calcium Chloride (0.1M) in DI water. The Endothelial cells were 
dispersed in the MGel and Alginate solution at 1 x 106 cell mL-1. Semi-IPN or IPN is different with or 
without UV exposure (320nm) during 1 min.
6.2.3. In vitro evaluation of Gels using Semi IPN and IPN structure
6.2.3.1. Viability and proliferation
The viability of the cells encapsulated in the microgels were measured using LIVE/DEAD Cell 
Viability Assay kit (Thermo Fisher), following the manufacturer’s instructions. Briefly, the cell-laden 
gel was treated with calcein-AM and ethidium homodimer-1 to fluorescently label live (green) and dead 
(red) cells, and were visualized with fluorescence microscopy (XDS-3FL, Optika). The viability was 
reported as the percentage of live cells from the total number of cells. The proliferation rate (kP) of 
encapsulated cells was determined by counting the number of live cells at various time points up to 7 







Nt was the number of viable cells at time, t, and N0 was the initial number of viable cells at t=0.8-10
6.2.4. Facile generation of cell-laden hollow fiber
We made a new needle formation which can allow to generate hollow fiber as shown Figure X. Inside 
of tube consisted of hollow formation using Calcium Chloride 0.05M, FBS 10% and HEPES 25mM in 
Distilled water. Outer phase which are Alginate and MGel mixture is included endothelial cell. As 
shown Figure X. The syringe pump flow rates are same both inner and outer phase 800 μl/min. Calcium 
Chloride concentration is 0.3M, FBS 10% and HEPES 25mM in Distilled water.4
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6.3. Results and Discussion
Figure 6.1. This schematic represents overall experiments. (a) Alginate and MGel mixed Ca2+ as a 
physical cross-linking using Alginate (Semi-IPN) after then chemical cross-linking by UV exposure 
using MGel (IPN). (b) IPN structure can be removed physically cross-linked Alginate by Sodium Citrate. 
(c) Generating of hollow fiber using same methods.
6.3.1. Fabrication of endothelial cell laden gel
In this study, we explored various having stiffness gel and compare to semi-IPN or IPN. We performed 
cell encapsulated gel using syringe. Semi-IPN and IPN can be separated condition by with or without 
UV exposure. When UV exposure to the gel, which can convert to IPN condition. However, when UV 
not exposure to the gel, which can maintain semi-IPN formation (Figure 1a). With IPN gel formation, 
Alginate can be made pore through removed alginate via Sodium Citrate. Therefore, the structure 
remained MGel backbone (Figure 1b). At first, we can generate cell laden gel in order to check elastic 
modulus or swelling ratio. With same method, we performed to mimic blood vessel using endothelial 
cell (Figure 1c). 
6.3.2. Physical properties of Microgel using Semi IPN and IPN structure
6.3.2.1. Elastic modulus and swelling ratio
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Figure 6.2. (a) and (c) Elastic moduli (E) and Swelling ratios (Q) of Alginate 0.5% and MGel mixed 
Semi-IPN and IPN (b) and (d) Elastic moduli (E) and Swelling ratios (Q) of Alginate 1% and MGel 
mixed Semi-IPN and IPN.
 One of the advantages of hydrogel is that we can control the stiffness by changing hydrogel 
concentration. Figure 2 indicates that Elastic modulus and swelling ratios with Alginate and MGel at 
various concentration. As expected, Alginate concentration is higher as well as elastic modulus also 
increased. MGel concentration is higher as well as elastic modulus also increased. However, the trend 
in swelling ratio was opposite to that of elastic modulus since the porosity within the hydrogel becomes 
reduced with increasing crosslinking density. 
6.3.2.2 SEM structure of IPN structure
Figure 6.3. SEM images of IPN structure (Alginate 1% and MGel 8%, 10%, 12%, 15%) (scale bar: 10 
μm) 
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Figure 3 shows that SEM images of IPN structure at various MGel concentration. MGel concentration 
is increased as well as the pore size is decreased because of high cross-linking density. These results 
were correlated with the modulus and swelling ratio results mentioned above. 
6.3.3. In vitro evaluation of Microgels using Semi IPN and IPN structure
6.3.3.1 Viability and proliferation
It is well established that the mechanical cues imparted by the surrounding matrices exert significant 
effects on residing cells by signal transduction through focal adhesion.5 Therefore, it was hypothesized 
that the mechanical properties of the microgels, controlled by the concentration of MGel, would 
influence the 3T3 activities. The viability of 3T3 cells encapsulated within the microgels having 
different rigidity was assessed at various time points (Figure 4a and 4b) with or without UV exposure 
in order to make Semi-IPN or IPN structure. The initial viability, taken at day 1, were very low live cell 
observed in all conditions. At higher MGel concentrations, there was increased cell viability regardless 
Semi-IPN or IPN structure. This was made possible because the microgel consisted of crosslinked 
network of gelatin, which is derived from natural collagen and retains cell responsive moieties such as 
Arg-Gly-Asp (RGD) peptide and matrix metalloproteinase (MMP) recognition domains.6, 7 The 
proliferation rate of 3T3 in microgels at various MGel concentrations was calculated to assess the effect 
of mechanical properties on the encapsulated cells (Figure 4c and 4d). The increase in the number of
live cells (Nt/N0) were counted at different times up to 7 days. The proliferation rate (kP) was obtained
by fitting the plot with a power-law model (Figure 4e). The kP value was increased as well as MGel 
concentration increased. Interestingly, Semi-IPN microgel is higher cell viability rather than IPN
microgel. This could be the result of diminished permeability of the microgels with increased 
crosslinking density preventing further growth, similar to previous studies demonstrating the combined 
effects of mechanical and diffusional properties of hydrogels on the cells in 3D.
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Figure 6.4. Cell viability and proliferation in microgel. Representative microscopic(left) and 
fluorescent (right) images of 3T3 encapsulated in microgel taken at various times up to 7days. The cells 
were fluorescently stained to identify live (green) and dead (red) cells. (a) Semi-IPN structure (b) IPN 
structure (c) and (d) The normalized number of viable cells (Nt/N0) in microgel was measured over time 
(Nt: number of viable cells at time, t, N0: number of initial viable cells) Semi-IPN and IPN. (e) The plot 
in panel (c) and (d) were fitted with a power-law model to obtain the proliferation rate (kP).
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6.3.4. Effect of Sodium Citrate (Removing Alginate)
Figure 6.5. These images show the process which is removed alginate from IPN microgel in various 
time.
Figure 5 represents the process which is removed alginate from IPN microgel in various time. First 
image is alginate and MGel mixed microgel after UV exposure. Second image shows when sodium 
citrate (0.1M) exposed into the IPN microgel. At that time, the microgel was stared blur because of 
removing alginate and simultaneously generating porosity. Overtime, however, the opaque microgels 
became transparent again after the alginate was completely drained.
6.3.5. Facile generation of cell-laden hollow fiber
Figure 6.6. Scheme of generation of hollow fiber using alginate and MGel with HUVECs outer phase 
and inner phase 0.05M calcium chloride, 10% FBS, 25mM HEPES.
 Figure 6 indicates that how to generate hollow fiber using needle and borosilicate glass. We performed 
two kind of blood vessel such as Semi-IPN or IPN structure by with or without UV exposure. We try to 
cut off the vessel about 1cm fragmentation. After then, we cultured up to 7days and observed cell 
viability through live/dead assay. Figure 7 (a) shows mimic blood vessel image and Figure 7 (b) is 
observed by microscopic to confirm whether hollow fiber or not. As a result, that has hollow fiber 
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formation.
Figure 6.7. (a) Hollow fiber to mimic blood vessel using Alginate and MGel. (b) Microscopic image of 
hollow fiber.
Figure 6.8. Cell viability and proliferation in hollow fiber with HUVECs. Representative 
microscopic(left) and fluorescent (right) images of HUVECs encapsulated in microgel taken at various 
times up to 7days. These images show at 7days. The cells were fluorescently stained to identify live 
(green) and dead (red) cells. (a) Semi-IPN structure (b) IPN structure.
As I mentioned before, we performed two kind of hollow fiber to mimic blood vessel such as Semi-
IPN or IPN structure by with or without UV exposure. Figure 8 (a) is mimicking blood vessel having 
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Semi-IPN structure and Figure 8 (b) is mimicking blood vessel having IPN structure. The cell viability 
is very depended on hydrogel stiffness. At low stiffness having hydrogels, there are low cell viability 
observed regardless of semi-IPN or IPN structure. In all conditions, cell encapsulated microgels at semi-
IPN did not proliferate because of very low elastic modulus. However, hydrogel stiffness increased as 
well as the cell viability also increased. 
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6.4. Conclusion
We try to generate hollow fiber to mimic blood vessel using semi-IPN or IPN structure. By controlling 
concentration of Alginate and MGel mixture, we can obtain tunable cell encapsulated microgel. At first, 
we observed cell viability which is encapsulated microgel by dripping method. Alginate concentration 
is higher as well as elastic modulus also increased. MGel concentration is higher as well as elastic 
modulus also increased. However, the trend in swelling ratio was opposite to that of elastic modulus 
since the porosity within the hydrogel becomes reduced with increasing crosslinking density. The cell 
viability is very depended on hydrogel stiffness regardless semi-IPN or IPN structure. The proliferation 
rate (kP) was obtained by fitting the plot with a power-law model. The kp value was increased as well as 
MGel concentration increased. Interestingly, semi-IPN microgel is higher cell viability rather than IPN 
microgel. This could be the result of diminished permeability of the microgels with increased 
crosslinking density preventing further growth. To mimic blood vessel case, also shows same result. At 
low stiffness having hydrogels, there are low cell viability observed regardless of semi-IPN or IPN 
structure. However, hydrogel stiffness increased as well as the cell viability also increased. We observed 
by microscopic to confirm whether hollow fiber or not. As a result, that has hollow fiber formation. We 
have planned to closer mimic blood vessel using Smooth muscle cell. 
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